

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and managing... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-312/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-312" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease.">
            <meta name="og:description" content="Read the latest article version by Annarein J. C. Kerbert, Rajiv Jalan, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="24468">
            <meta name="article-id" content="22183">
            <meta name="dc.title" content="Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease">
            <meta name="dc.description" content="Hepatic encephalopathy (HE) is a common, severe complication of advanced chronic liver disease (CLD) and has a devastating impact on the patient&rsquo;s quality of life and prognosis. The neurotoxin ammonia and the presence of systemic and neurological inflammation are considered the key drivers of this neuropsychiatric syndrome. Treatment options available in routine clinical practice are limited, and the development of novel therapies is hampered owing to the complexity and heterogeneity of HE. This review article aims to outline the current understanding of the pathomechanisms of HE and the recent advances in the identification and development of novel therapeutic targets.">
            <meta name="dc.subject" content="Hepatic encephalopathy, hyperammonemia, inflammation, chronic liver disease">
            <meta name="dc.creator" content="Kerbert, Annarein J. C.">
            <meta name="dc.creator" content="Jalan, Rajiv">
            <meta name="dc.date" content="2020/04/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.22183.1">
            <meta name="dc.source" content="F1000Research 2020 9:312">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Hepatic encephalopathy">
            <meta name="prism.keyword" content="hyperammonemia">
            <meta name="prism.keyword" content="inflammation">
            <meta name="prism.keyword" content="chronic liver disease">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/04/29">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="312">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.22183.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-312">
            <meta name="citation_title" content="Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease">
            <meta name="citation_abstract" content="Hepatic encephalopathy (HE) is a common, severe complication of advanced chronic liver disease (CLD) and has a devastating impact on the patient&rsquo;s quality of life and prognosis. The neurotoxin ammonia and the presence of systemic and neurological inflammation are considered the key drivers of this neuropsychiatric syndrome. Treatment options available in routine clinical practice are limited, and the development of novel therapies is hampered owing to the complexity and heterogeneity of HE. This review article aims to outline the current understanding of the pathomechanisms of HE and the recent advances in the identification and development of novel therapeutic targets.">
            <meta name="citation_description" content="Hepatic encephalopathy (HE) is a common, severe complication of advanced chronic liver disease (CLD) and has a devastating impact on the patient&rsquo;s quality of life and prognosis. The neurotoxin ammonia and the presence of systemic and neurological inflammation are considered the key drivers of this neuropsychiatric syndrome. Treatment options available in routine clinical practice are limited, and the development of novel therapies is hampered owing to the complexity and heterogeneity of HE. This review article aims to outline the current understanding of the pathomechanisms of HE and the recent advances in the identification and development of novel therapeutic targets.">
            <meta name="citation_keywords" content="Hepatic encephalopathy, hyperammonemia, inflammation, chronic liver disease">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Annarein J. C. Kerbert">
            <meta name="citation_author_institution" content="Institute for Liver and Digestive Health, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK">
            <meta name="citation_author" content="Rajiv Jalan">
            <meta name="citation_author_institution" content="Institute for Liver and Digestive Health, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK">
            <meta name="citation_publication_date" content="2020/04/29">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="312">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.22183.1">
            <meta name="citation_firstpage" content="312">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-312/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-312.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=24468 /> <input type=hidden id=articleId name=articleId value=22183 /> <input type=hidden id=xmlUrl value="/articles/9-312/v1/xml"/> <input type=hidden id=xmlFileName value="-9-312-v1.xml"> <input type=hidden id=article_uuid value=e8c634dd-eea7-466a-8118-5beb9d9eaf4d /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.22183.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.22183.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-312"
  },
  "headline": "Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease",
  "datePublished": "2020-04-29T15:25:19",
  "dateModified": "2020-04-29T15:25:19",
  "author": [
    {
      "@type": "Person",
      "name": "Annarein J. C. Kerbert"
    },    {
      "@type": "Person",
      "name": "Rajiv Jalan"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Hepatic encephalopathy (HE) is a common, severe complication of advanced chronic liver disease (CLD) and has a devastating impact on the patient&rsquo;s quality of life and prognosis. The neurotoxin ammonia and the presence of systemic and neurological inflammation are considered the key drivers of this neuropsychiatric syndrome. Treatment options available in routine clinical practice are limited, and the development of novel therapies is hampered owing to the complexity and heterogeneity of HE. This review article aims to outline the current understanding of the pathomechanisms of HE and the recent advances in the identification and development of novel therapeutic targets."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-312/v1",
            "name": "Recent advances in understanding and managing hepatic encephalopathy..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and managing hepatic encephalopathy... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=24468 data-id=22183 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22183.1" data-recommended="" data-doi="10.12688/f1000research.22183.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-312/v1/pdf?article_uuid=e8c634dd-eea7-466a-8118-5beb9d9eaf4d" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-22183-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-22183-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-22183-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Kerbert AJC and Jalan R. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):312 (<a class=new-orange href="https://doi.org/10.12688/f1000research.22183.1" target=_blank>https://doi.org/10.12688/f1000research.22183.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-22183-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=22183 id=track-article-signin-22183 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22183?target=/articles/9-312/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=24468 /> <input name=articleId type=hidden value=22183 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Annarein J. C. Kerbert,&nbsp;</span><span class=""><a href="mailto:r.jalan@ucl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rajiv Jalan</span></a><a href="https://orcid.org/0000-0001-9845-2176" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9845-2176</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Annarein J. C. Kerbert,&nbsp;</span><span class=""><a href="mailto:r.jalan@ucl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rajiv Jalan</span></a><a href="http://orcid.org/0000-0001-9845-2176" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9845-2176</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Apr 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.22183.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Institute for Liver and Digestive Health, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK<br/> <p> <div class=margin-bottom> Annarein J. C. Kerbert <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation </div> <div class=margin-bottom> Rajiv Jalan <br/> <span>Roles: </span> Conceptualization, Supervision, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25428-62903></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=66990-62902></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Hepatic encephalopathy (HE) is a common, severe complication of advanced chronic liver disease (CLD) and has a devastating impact on the patients quality of life and prognosis. The neurotoxin ammonia and the presence of systemic and neurological inflammation are considered the key drivers of this neuropsychiatric syndrome. Treatment options available in routine clinical practice are limited, and the development of novel therapies is hampered owing to the complexity and heterogeneity of HE. This review article aims to outline the current understanding of the pathomechanisms of HE and the recent advances in the identification and development of novel therapeutic targets. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Hepatic encephalopathy, hyperammonemia, inflammation, chronic liver disease </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Rajiv Jalan (<a href="mailto:r.jalan@ucl.ac.uk">r.jalan@ucl.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Rajiv Jalan </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Annarein J. C. Kerbert declares that she has no competing interests. Rajiv Jalan has research collaborations with Yaqrit and Takeda. Rajiv Jalan is the inventor of OPA, which has been patented by University College London and licensed to Mallinckrodt Pharma. He is also the founder of Yaqrit Ltd, a spin out company from University College London. He is also a Founder of Thoeris Ltd. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2020 Kerbert AJC and Jalan R. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Kerbert AJC and Jalan R. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.22183.1" target=_blank>https://doi.org/10.12688/f1000research.22183.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Apr 2020, <b>9</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.22183.1" target=_blank>https://doi.org/10.12688/f1000research.22183.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Apr 2020, <b>9</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.22183.1" target=_blank>https://doi.org/10.12688/f1000research.22183.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d15633e142>Introduction</h2><p class="" id=d15633e145>In patients with advanced liver disease, liver insufficiency and/or portosystemic shunting may lead to the occurrence of a wide range of neuropsychiatric symptoms<sup><a href="#ref-1">1</a></sup>. This brain dysfunction, known as hepatic encephalopathy (HE), marks the end-stage of chronic liver disease (CLD) and has disastrous consequences for the quality of life of patients and their caregivers<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. HE is a common feature in CLD, as it will develop in about 3040% of patients at some point during the course of the disease. HE can be classified as overt (West Haven grade IIIV, diagnosed based on clinical symptoms ranging from disorientation to coma) or covert (minimal HE or West Haven grade I, diagnosis requiring specialist neuropsychologic testing [<a href="#T1">Table 1</a>])<sup><a href="#ref-1">1</a></sup>. Overt HE development is unpredictable and rapid and often requires admission to the intensive care unit<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. Prognosis of these patients is poor; unless there is access to liver transplantation, 1-year survival generally does not exceed 40%<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Also, minimal HE (mHE) is associated with a significant impact on quality of life and an increased risk of development of overt HE, hospital admission, and death. Despite advances in the understanding of HE and the development of novel therapies, recent data point out that it is still the leading cause for readmission and mortality in CLD<sup><a href="#ref-5">5</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. WHC and ISHEN classification (modified according to Vilstrup <i>et al</i>.<sup><a href="#ref-1">1</a></sup>).</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15633e203 class=n-a></a><thead><a name=d15633e205 class=n-a></a><tr><a name=d15633e207 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15633e209 class=n-a></a>WHC grade</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15633e212 class=n-a></a>ISHEN</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15633e215 class=n-a></a>Clinical features</th></tr></thead><tbody><a name=d15633e220 class=n-a></a><tr><a name=d15633e222 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d15633e224 class=n-a></a>Unimpaired</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e227 class=n-a></a>No present or previous HE</td></tr><tr><a name=d15633e231 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e233 class=n-a></a>Minimal</td><td align=left colspan=1 rowspan=2 valign=top><a name=d15633e236 class=n-a></a>Covert</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e239 class=n-a></a>Alterations of psychometric or<br class=br>neuropsychological tests (i.e. PHES,<br class=br>CFF, EEG) without clinical manifestations</td></tr><tr><a name=d15633e247 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e249 class=n-a></a>Grade I</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e252 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Trivial lack of awareness<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Euphoria or anxiety<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Shortened attention span<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Impairment of addition or subtraction<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Altered sleep rhythm</td></tr><tr><a name=d15633e264 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e266 class=n-a></a>Grade II</td><td align=left colspan=1 rowspan=3 valign=top><a name=d15633e269 class=n-a></a>Overt</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e272 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Lethargy or apathy<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Disorientation for time<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Obvious personality change<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Inappropriate behavior<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Dyspraxia<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Asterixis</td></tr><tr><a name=d15633e286 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e288 class=n-a></a>Grade III</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e291 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Somnolence to semi-stupor<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Responsive to stimuli<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Confused<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Gross disorientation<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Bizarre behavior</td></tr><tr><a name=d15633e304 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e306 class=n-a></a>Grade IV</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e309 class=n-a></a>Coma</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d15633e317 class=n-a></a><p id=d15633e319> CFF, Critical Flicker Frequency; EEG, electroencephalography; HE, hepatic encephalopathy; ISHEN, International Society for Hepatic Encephalopathy and Nitrogen Metabolism; PHES, Psychometric Hepatic Encephalopathy Score; WHC, West Haven Criteria.</p></div></div></div><p class="" id=d15633e325>Although it is well established that the neurotoxin ammonia is key in the pathogenesis of HE, the neurochemical changes following ammonia metabolism are numerous and not all yet fully understood. Moreover, distinct pathomechanisms such as alterations in cerebral blood flow (CBF) and, more recently, inflammation have been shown to contribute. The heterogeneity of the clinical presentation as well as the complex and multifactorial pathogenesis of HE have hampered the optimization of its management and the development of effective therapies. This article aims to review the most recent advances in understanding of the disease, with a focus on ammonia and inflammation, and the translation into clinical management. Moreover, the future perspectives of the most promising therapeutic opportunities will be discussed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15633e331>Recent advances in understanding the complex pathophysiology</h2><div class=section><a name=d15633e334 class=n-a></a><h3 class=section-title>Ammonia: the traditional hypothesis</h3><p class="" id=d15633e339>Of all neurotoxin candidates that have been studied over the last century to explain the neuropsychiatric phenotype in liver disease patients, ammonia has been investigated and discussed most extensively. Ammonia is a nitrogenous compound that is mainly derived from bacterial production and amino acid metabolism in the gut<sup><a href="#ref-8">8</a><a href="#ref-10">10</a></sup>. In healthy individuals, ammonia is metabolized in the liver by the urea cycle and glutamine synthetase (GS) and subsequently excreted by the kidneys. The very first link between ammonia and HE dates back almost a century (1922), when a causal relationship between ammonia and meat intoxication was reported in dogs with a portocaval shunt<sup><a href="#ref-11">11</a></sup>. Later (1954), the significance of portal-systemic shunting in cirrhosis in the pathogenesis of HE was reported by Sheila Sherlock <i>et al</i>.<sup><a href="#ref-12">12</a></sup>. They measured peripheral and hepatic venous blood levels of ammonia in CLD patients following oral ammonium chloride intake and showed that ammonia can enter the systemic circulation via the gut by passing through a cirrhotic liver and/or by bypassing it via portal-systemic collaterals. This was therefore defined by the term portal-systemic HE. This circulating ammonia is then able to cross the bloodbrain barrier (BBB), where it induces a cascade of deleterious effects on the brain<sup><a href="#ref-13">13</a></sup>.</p></div><div class=section><a name=d15633e365 class=n-a></a><h3 class=section-title>Ammonia: advances in understanding its cerebral effects</h3><p class="" id=d15633e370>Once ammonia reaches the brain, its metabolism mainly relies on glutamine synthesis via GS, which is almost exclusively located in the astrocytes<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>. In physiological states, GS is already acting near its maximum rate, thereby efficiently converting ammonia into glutamine. However, in the setting of hyperammonemia, the brain becomes less efficient in ammonia removal because of an insufficient upregulation of GS activity and the absence of an alternative removal pathway<sup><a href="#ref-16">16</a></sup>. Nevertheless, glutamine concentrations are well known to be markedly increased in the brains of animals and patients with HE<sup><a href="#ref-16">16</a><a href="#ref-18">18</a></sup>. Inhibition of glutamine breakdown by ammonia has been suggested to be a contributing factor<sup><a href="#ref-19">19</a></sup>. Increased cytosolic glutamine creates an osmotic gradient and thereby contributes to the characteristic morphological changes and mild swelling of the astrocytes in chronic hyperammonemia, known as Alzheimer type II astrocytosis<sup><a href="#ref-20">20</a></sup>. Also, ammonia-related changes in the expression of key astrocytic proteins, such as glial fibrillary acidic protein<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup> and peripheral type benzodiazepine receptors<sup><a href="#ref-23">23</a><a href="#ref-25">25</a></sup>, contribute to the altered astrocyte morphology and dysfunction.</p><p class="" id=d15633e414>Besides low-grade brain edema and astrocyte dysfunction, HE in CLD seems to be characterized by a global (ammonia-induced) depression of the central nervous systems function. This is reflected by 1) a net increase in inhibitory neurotransmission (mainly via impairment of the glutamate neurotransmitter system)<sup><a href="#ref-26">26</a><a href="#ref-28">28</a></sup>, 2) reduced CBF<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>, 3) reduced oxygen consumption and brain oxygenation<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>, and 4) reduced energy metabolism<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. All of these factors seem to be closely interconnected, and imaging studies in cirrhotic patients with chronic hyperammonemia show similar redistribution patterns for CBF and the cerebral metabolic rate for glucose (CMR<sub>glucose</sub>), characterized by a decrease in the cortical and an increase in certain subcortical areas<sup><a href="#ref-35">35</a></sup>. This corresponds with regions of ammonia-induced suppression of brain metabolism and neurotransmission<sup><a href="#ref-36">36</a></sup>. The link between HE and impaired energy metabolism was first suggested in 1955<sup><a href="#ref-37">37</a></sup>. Thereafter, studies showed that key processes such as glycolysis<sup><a href="#ref-38">38</a><a href="#ref-40">40</a></sup>, the tricarboxylic acid cycle (TCA)<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>, and the electron transport chain (ETC)<sup><a href="#ref-43">43</a><a href="#ref-45">45</a></sup> are affected by ammonia. An increased rate of glycolysis is a well-characterized phenomenon in HE and hyperammonemia. Although increased glycolysis would be anticipated to increase the operational rate of the TCA cycle, this is not the case in hyperammonemia. Instead of being used in the TCA cycle, pyruvate produced during glycolysis is converted into lactate<sup><a href="#ref-40">40</a>,<a href="#ref-46">46</a></sup>. Diminished availability of pyruvate in hyperammonemia may lead to a decreased operational rate of the TCA cycle, ETC (reduced oxaloacetate generation and availability of NAD/NADH), and ultimately ATP production<sup><a href="#ref-47">47</a></sup>. Reduced brain ATP levels have been reported in experimental models of both acute and chronic hyperammonemia<sup><a href="#ref-33">33</a>,<a href="#ref-48">48</a><a href="#ref-50">50</a></sup>. Whether reduced brain ATP levels reflect suppressed synthesis or increased consumption is not yet fully elucidated. More recent studies have been focusing on the role of ammonia-induced mitochondrial dysfunction as an underlying mechanism of impaired energy metabolism in HE. Particularly, the mitochondrial permeability transition (mPT) has been suggested to play a central role. It is characterized by a sudden increase in permeability of the inner mitochondrial membrane to small molecules by opening of the permeability transition pore (PTP)<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. The most important triggers of PTP opening are increased mitochondrial Ca<sup>2+</sup> and (ammonia-/glutamine-induced) production of reactive oxygen species (ROS)<sup><a href="#ref-53">53</a></sup>. This then leads to depolarization of the mitochondrial membrane potential, osmotic swelling of the mitochondrial matrix, uncoupling of the ETC, and thus inhibition of ATP synthesis. Ammonia has been shown to induce an early increase in intracellular Ca<sup>2+</sup> in cultured astrocytes and subsequent induction of mPT<sup><a href="#ref-54">54</a><a href="#ref-57">57</a></sup>. Although results of various <i>in vivo</i> and <i>in vitro</i> studies of acute and chronic hyperammonemia support the role of ammonia in disturbed energy metabolism and mitochondrial dysfunction, it must be noted that conflicting results exist<sup><a href="#ref-47">47</a></sup>. This may be partly explained by differences in studied brain regions, cell types, and ammonia concentration and durations. The chronological order of events and interrelationships among changes in neurotransmission, CBF, and oxygen and energy metabolism are yet to be clarified and may guide us to better understand this complex condition and ultimately to develop novel therapeutic strategies.</p><p class="" id=d15633e539>A recently opened field in the exploration of the pathogenesis of HE is ammonia-induced cellular senescence of astrocytes. It has been described that ammonia can induce senescence via glutamine synthesis-dependent formation of ROS, p53 activation, and upregulation of cell cycle inhibitors (p21 and GADD45a)<sup><a href="#ref-58">58</a></sup>. Another study describes a role for heme oxygenase (HO)-1 in mediating ammonia-induced inhibition of astrocyte proliferation in cultures<sup><a href="#ref-59">59</a></sup>. Although it is currently unknown whether there is a role for astrocyte senescence in the development of cognitive impairment in HE, it seems to have exciting implications for explaining the increasing evidence that cognitive dysfunction does not fully reverse in all patients who experienced an acute episode of HE and may even persist after liver transplantation.</p></div><div class=section><a name=d15633e551 class=n-a></a><h3 class=section-title>Ammonia: the refined hypothesis</h3><p class="" id=d15633e556>The above-described selection of deleterious effects of ammonia on the brain form the basis of the traditional ammonia hypothesis. This is supported by the fact that ammonia-lowering therapies improve symptoms and outcome in HE, which are therefore the current cornerstones of therapy<sup><a href="#ref-1">1</a></sup>. However, this hypothesis is often criticized, mainly because the clinical value of ammonia measurements is, to date, still unclear, as plasma levels do not always correlate well with severity and outcome<sup><a href="#ref-60">60</a></sup>. This observation suggests that in different clinical situations the effect of ammonia on the brain may well be different. Features in cirrhosis such as inflammation, malnourishment, sodium levels, sarcopenia, co-morbidities, renal dysfunction/failure, and gastrointestinal bleeding (high intestinal protein load) may be some of the contributory factors.</p></div><div class=section><a name=d15633e568 class=n-a></a><h3 class=section-title>Systemic inflammation in chronic liver disease: role in hepatic encephalopathy</h3><p class="" id=d15633e573>The poor correlation between circulating ammonia levels and HE severity in CLD led to the hypothesis that other mechanisms are involved. Systemic inflammation, commonly referred to as systemic inflammatory response syndrome (SIRS), is a common phenomenon in CLD and can occur in the context of non-sterile (i.e. bacterial infection) as well as sterile inflammation<sup><a href="#ref-61">61</a></sup>. It is characterized by the systemic release of pro-inflammatory cytokines (cytokine storm), which may subsequently culminate in severe impairment of systemic hemodynamics and organ hypoperfusion, organ inflammation, cell death, microvascular damage, and eventually (multi-) organ failure. It is well described that sepsis without underlying liver disease can present similarly to HE with altered mental state and motor function, a condition also referred to as septic encephalopathy<sup><a href="#ref-62">62</a></sup>. This indicates that a pro-inflammatory state itself can precipitate an encephalopathic state. Previous studies have shown that the vast majority of patients admitted with severe HE indeed present with evidence of systemic inflammation<sup><a href="#ref-63">63</a></sup>. Moreover, patients with CLD are generally immunosuppressed and therefore prone to infections, which are well-recognized precipitants of overt HE<sup><a href="#ref-64">64</a></sup>. The presence of systemic inflammation has been found to significantly impact on mortality risk, and pro-inflammatory markers correlate well with the severity of HE. Also, in patients with mHE, serum levels of pro-inflammatory cytokines are increased (IL-6, IL-18) and correlate with the degree of neurocognitive dysfunction and driving ability<sup><a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>.</p><p class="" id=d15633e599>Peripheral inflammation can lead to neuroinflammation via several pathways, of which the humoral (circulating cytokines) and immune (activated immune cells) pathways are the most important<sup><a href="#ref-67">67</a></sup>. Firstly, translocation of Gram-negative bacteria across the intestinal barrier and the release of bacterial products (i.e. pathogen-associated molecular patterns [PAMPs]) play an important role in the development of systemic inflammation in CLD<sup><a href="#ref-68">68</a></sup>. PAMPs, such as lipopolysaccharide (LPS), bind to pattern recognition receptors resulting in the release of pro-inflammatory cytokines. Circulating cytokines can directly enter the brain by impacting on the permeability of the BBB or by binding to receptors of pro-inflammatory cytokines (TNF, IL1) expressed by endothelial cells in the BBB<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>. Subsequently, this leads to the release of secondary messenger molecules into the brain. These molecules (such as prostaglandins and nitric oxide [NO]) can induce the activation of microglia that can themselves produce inflammatory mediators. Secondly, activated immune cells can similarly bind to endothelial cells in the BBB, thereby inducing the release of secondary messenger molecules and microglia activation. There is a high number of studies providing evidence of microglia activation in the brains of both rodent models and patients with HE. This neuroinflammatory state can lead to changes in neurotransmission, oxidative stress, and neuronal cell death, as shown in both <i>in vitro</i> and <i>in vivo</i> studies<sup><a href="#ref-71">71</a><a href="#ref-73">73</a></sup>.</p><p class="" id=d15633e631>Besides the alterations in intestinal integrity and increased bacterial translocation in CLD, an upcoming field in exploring the role of the gutbrain axis in HE is the gut microbiome. Considering the disrupted intestinal barrier and suppressed immune system in CLD, it is not surprising that dysbiosis of gut microflora can contribute to inducing peripheral inflammation in CLD. Characteristic changes in microbiome associated with HE have been found to correlate with cognitive function and systemic inflammation and involve an abundance of non-autochthonous microorganisms such as <i>Veillonellaceae, Alcaligenaceae, Enterococcus, Megasphaera, Burkholderia, Streptococcus salivarius, Staphylococcaceae, Porphyromonadaceae</i>, and <i>Lactobacillaceae</i><sup><a href="#ref-74">74</a><a href="#ref-76">76</a></sup>. Similar findings have been reported in both stool and salivary microbiota. This suggests that a global gastrointestinal dysbiosis strongly correlates with cognition and inflammation in CLD and therefore holds prognostic and therapeutic potential in HE<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a></sup>.</p></div><div class=section><a name=d15633e655 class=n-a></a><h3 class=section-title>Systemic inflammation in chronic liver disease: synergy with ammonia</h3><p class="" id=d15633e660>Increasing evidence points towards the fact that hyperammonemia and systemic inflammation are not two distinct mechanisms driving the severity of HE but that they are working synergistically by making the brain more susceptible to each others effects. An elegant clinical study by Shawcross <i>et al</i>. showed for the first time that scores of neuropsychological tests in stable cirrhotic patients are declining when hyperammonemia is induced in an inflammatory state but not after the infection has resolved<sup><a href="#ref-79">79</a></sup>. This synergism was later confirmed in animal models of CLD, showing that the administration of LPS results in hyperammonemia, brain swelling, and coma<sup><a href="#ref-80">80</a>,<a href="#ref-81">81</a></sup>. On the other hand, a reduction in blood ammonia was shown to protect the brain from a subsequent dosing of LPS, suggesting that not only does inflammation make the brain more susceptible to the effects of ammonia but also the reverse is true<sup><a href="#ref-82">82</a></sup>. Furthermore, hyperammonemia itself can directly induce microglia activation and neuroinflammation and appears to have a role in suppression of the immune system<sup><a href="#ref-83">83</a><a href="#ref-85">85</a></sup>. Induction of hyperammonemia in rats is associated with impaired neutrophil phagocytic activity leading to ROS production, thereby contributing to systemic inflammation and predisposing infections. Although the precise underlying mechanisms of the synergy between ammonia and inflammation in driving HE severity are not yet fully understood, it may provide essential novel therapeutic targets.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15633e692>Future perspectives on novel therapeutic targets</h2><div class=section><a name=d15633e695 class=n-a></a><h3 class=section-title>Cornerstone pharmacotherapies: targeting the gut</h3><p class="" id=d15633e700>The pharmacotherapies for the treatment of HE traditionally target the gut. The two main treatments in current routine clinical practice are non-absorbable disaccharides (i.e. lactulose) and the poorly absorbed antibiotic rifaximin<sup><a href="#ref-1">1</a></sup>. Lactulose is traditionally the first-line treatment in CLD-related HE. It reduces circulating ammonia levels by different mechanisms: 1) modulation of intestinal flora and therefore reduction in urease-producing bacteria and 2) its laxative effect reduces diffusion of ammonia and nitrogenous compounds into the bloodstream. Lactulose plays an important role as a first-line treatment of HE and in secondary prophylaxis of recurrent overt HE. A recent meta-analysis once again confirmed its beneficial effect regarding HE resolution, development of liver-related complications, and mortality<sup><a href="#ref-86">86</a>,<a href="#ref-87">87</a></sup>. These data, together with this treatments low cost and small spectrum of side effects, support the recommendation for lactulose as the initial therapy for HE in CLD. However, as a first-line treatment of an acute HE episode, there is no robust evidence that lactulose improves mortality and outcome. Rifaximin is derived from rifamycin and has a broad spectrum of action against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria. Its mode of action is thought to be via modulation of the gut microbiota, thereby inducing a shift towards a less-pathogenic bacteria population and a reduction in ammonia, endotoxins, and pro-inflammatory cytokines. Addition of rifaximin to lactulose is recommended in patients with recurrent overt HE in CLD despite lactulose prophylaxis<sup><a href="#ref-1">1</a></sup>. In addition, several studies support the effectiveness of rifaximin in the setting of acute HE, but robust data showing improvement of survival in these patients are lacking<sup><a href="#ref-88">88</a>,<a href="#ref-89">89</a></sup>. Along with the globally increasing incidence of liver cirrhosis, the number of hospitalizations for HE has been continuing to grow over the last decade, despite the implementation of novel therapies, such as rifaximin<sup><a href="#ref-2">2</a>,<a href="#ref-5">5</a></sup>. Moreover, long-term antibiotic usage is associated with increased risk of infection with antibiotic-resistant strains of bacteria. Therefore, there is still a significant need for identifying and exploring novel therapeutic targets.</p></div><div class=section><a name=d15633e733 class=n-a></a><h3 class=section-title>Potential future therapies targeting the gut</h3><p class="" id=d15633e738>Probiotics have been studied in a small number of trials that reported positive results regarding primary prevention of HE, risk of HE-related hospitalization, and the severity of liver disease<sup><a href="#ref-90">90</a><a href="#ref-92">92</a></sup>. As for rifaximin, the mechanism of action is thought to be through modulation of the gut microbiome and metabolism. However, it should be noted that probiotics have been reported to be unsafe in some categories of patients, such as those with acute pancreatitis<sup><a href="#ref-93">93</a></sup>. A report released by the World Health Organization (WHO)/Food and Agriculture Organization (FA) (<a target=xrefwindow href="https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf" id=d15633e751>https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf</a>) describes four types of potential side effects, namely systemic inflammation, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, and gene transfer. A more recent report from the Agency for Healthcare Research and Quality (AHRQ) reviews the results of 622 studies and concludes that, based on the currently available literature, questions on the safety of probiotics cannot be entirely addressed<sup><a href="#ref-94">94</a></sup>. Another novel, upcoming approach to restore the gut dysbiosis is fecal microbiota transplantation (FMT). In pre-clinical studies, it has been proven that transplantation of fecal microbiota can effectively reduce ammonia levels<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>. A small number of clinical trials have shown promising results in terms of the safety/tolerability profile and efficacy (hospitalization, cognition, dysbiosis) of FMT<sup><a href="#ref-97">97</a>,<a href="#ref-98">98</a></sup>. However, a recent case report describes two patients included in two independent clinical trials (one of them had advanced CLD and refractory HE), who developed extended-spectrum beta-lactamase (ESBL)-producing <i>Escherichia coli</i> bacteremia after they had received FMT oral capsules derived from the same stool donor<sup><a href="#ref-99">99</a></sup>. Therefore, well-selected stool transplantation may be an attractive future target for the treatment of HE, but continuous research on the risks and benefits of FMT and the optimization of donor screening is needed.</p></div><div class=section><a name=d15633e782 class=n-a></a><h3 class=section-title>Targeting ammonia and nitrogen metabolism</h3><p class="" id=d15633e787>L-ornithine L-aspartate (LOLA) is a combination of two non-essential amino acids that can promote ammonia detoxification by acting as a substrate for the urea cycle and by activating GS<sup><a href="#ref-100">100</a></sup>. Intravenous administration has been reported to effectively reduce ammonia and improve mental state in overt HE, whereas the oral formulation seems effective in mHE by improving the outcome of psychometric tests<sup><a href="#ref-101">101</a></sup>. However, a recent Cochrane review states that the quality of evidence on the use of LOLA in HE is poor and further randomized controlled trials are needed<sup><a href="#ref-102">102</a></sup>. Therefore, administration of LOLA is currently restricted to countries in which it is approved for the treatment of HE. A potential risk of LOLA is the so-called rebound of ammonia production, as glutamine can be recycled into ammonia by glutaminases<sup><a href="#ref-103">103</a></sup>. The ammonia scavenger ornithine phenylacetate (OP) bypasses this issue by conjugating glutamine with phenylacetate, which forms a water-soluble molecule that can be excreted by the kidneys and hence prevents re-metabolism via glutaminase to glutamate and ammonia. OP was studied up to phase IIb trials and has been shown to safely and effectively reduce ammonia with a dose-related clinical improvement<sup><a href="#ref-104">104</a><a href="#ref-106">106</a></sup>. A planned phase III trial needs to confirm these findings.</p><p class="" id=d15633e813>Nitrogen scavengers that have been investigated in HE include sodium benzoate, glycerol phenylbutyrate, and sodium phenylbutyrate. These agents decrease ammonia by activating conjugation reactions, thereby promoting the elimination of waste nitrogen as amino acid conjugates instead of urea. Benzoate conjugates with glycine to form hippurate and phenylacetate with glutamine to form phenylacetylglutamine, which are both readily excreted by the kidneys<sup><a href="#ref-107">107</a>,<a href="#ref-108">108</a></sup>. Several trials have been showing a beneficial effect of these scavengers on ammonia levels and the risk of overt HE development<sup><a href="#ref-109">109</a></sup>. However, in a recent Cochrane review, it was concluded that the number of available studies is low and the quality of evidence poor at present<sup><a href="#ref-109">109</a></sup>. Furthermore, the high salt load required for sodium benzoate may imply a limited utility in the treatment of HE in CLD. Another approach that has been studied to reduce brain glutamine in HE is the inhibition of GS, for example by L-methionine-S,R-sulfoximine (MSO). Several pre-clinical studies have shown a beneficial effect of MSO on ammonia-induced astrocyte swelling and intracranial hypertension<sup><a href="#ref-110">110</a><a href="#ref-114">114</a></sup>. However, the translation of MSO to the clinical situation is hampered by the fact that it can cause convulsions, as observed in animal models<sup><a href="#ref-115">115</a>,<a href="#ref-116">116</a></sup>.</p><p class="" id=d15633e845>Finally, nutritional supplements, such as branch-chained amino acids (BCAAs) and zinc, have been studied. In the setting of impaired hepatic ammonia metabolism in CLD, skeletal muscle plays an important role in ammonia detoxification through glutamine synthesis by GS<sup><a href="#ref-117">117</a>,<a href="#ref-118">118</a></sup>. In cirrhosis, BCAAs are consumed in skeletal muscle to form -ketoglutarate, which may be depleted due to enhanced amination to glutamate and subsequent glutamine synthesis<sup><a href="#ref-119">119</a><a href="#ref-121">121</a></sup>. Clinical trials assessing BCAA supplementation for the treatment of HE showed mixed results and further studies are required<sup><a href="#ref-122">122</a><a href="#ref-126">126</a></sup>. Nevertheless, BCAA supplementation is safe and seems to be useful in preventing the deterioration of liver failure and nutritional status of the cirrhotic patient<sup><a href="#ref-127">127</a>,<a href="#ref-128">128</a></sup>.</p><p class="" id=d15633e876>Zinc, often deficient in CLD, is considered a cofactor of urea cycle enzymes, and low levels are associated with hyperammonemia and HE<sup><a href="#ref-129">129</a><a href="#ref-132">132</a></sup>. The potential benefit of zinc supplementation has been studied in several clinical trials showing largely beneficial effects in HE<sup><a href="#ref-133">133</a><a href="#ref-135">135</a></sup>. A recent meta-analysis concluded that a combination of zinc with lactulose over 36 months may improve the outcome of psychometric tests in patients with covert HE as compared to lactulose alone<sup><a href="#ref-136">136</a></sup>.</p></div><div class=section><a name=d15633e898 class=n-a></a><h3 class=section-title>Targeting systemic inflammation</h3><p class="" id=d15633e903>The concept of the beneficial effect of anti-inflammatory agents on HE has initially been shown for ibuprofen (NSAID) and indomethacin (a potent inhibitor of cyclooxygenase-2) in pre-clinical models of HE<sup><a href="#ref-83">83</a>,<a href="#ref-137">137</a><a href="#ref-139">139</a></sup>. However, it needs to be considered that these non-steroidal anti-inflammatories are not indicated in the context of CLD because of their deleterious effects on kidney function and impact on risk of gastrointestinal bleeding. Currently, the majority of studies are focusing on reducing the degree of endotoxemia and systemic inflammation by gut-targeting therapies as described above. Also, albumin administration has been studied as a treatment for HE. Besides its property to promote the maintenance of systemic oncotic pressure, albumin is able to scavenge toxins, has anti-oxidant properties, and stabilizes endothelial function<sup><a href="#ref-140">140</a></sup>. However, albumin was found to be ineffective in improving HE severity, ammonia levels, and markers of oxidative stress and inflammation in clinical trials, but it prolonged survival<sup><a href="#ref-141">141</a>,<a href="#ref-142">142</a></sup>. However, although no survival benefit was reported when albumin was applied in extracorporeal liver assist devices (i.e. MARS), it was associated with a decline in HE severity<sup><a href="#ref-143">143</a></sup>. This dialysis system may have its indication in HE as a bridge to transplantation or spontaneous clinical improvement in specialized centers.</p><p class="" id=d15633e931>A few approaches have been studied to target neuroinflammation directly. N-methyl-D-aspartate (NMDA) receptors are known to play an important role in some types of learning. The function of these receptors is reduced in models of chronic hyperammonemia<sup><a href="#ref-144">144</a></sup>. Activation of these receptors increases calcium in postsynaptic neurons, thereby increasing NO and cyclic guanine monophosphate (cGMP). This so-called glutamateNOcGMP pathway plays a key role in inhibiting neuroinflammation and promoting neural cell survival. Sildenafil is a phosphodiesterase inhibitor that inhibits the degradation of cGMP and thereby improves the function of the glutamateNOcGMP pathway. Sildenafil has been shown to improve learning abilities in rodent models of minimal HE. In addition, it has been reported to reduce neuroinflammation<sup><a href="#ref-145">145</a><a href="#ref-147">147</a></sup>. Targeting the NMDA receptors directly is clinically difficult because in acute hyperammonemia (in contrast to its behavior during chronic hyperammonemia) the NMDA receptors are highly activated and account for ammonia-induced mortality<sup><a href="#ref-144">144</a></sup>. Other studied approaches to reduce neuroinflammation involve reducing microglial activation directly by inhibiting the p38 mitogen-activated protein kinase<sup><a href="#ref-148">148</a>,<a href="#ref-149">149</a></sup>. Agusti <i>et al</i>. showed that inhibiting p38 reduces neuroinflammation (microglial activation and inflammatory markers) and improves cognitive and motor function (learning ability, motor activity, and coordination) in rats with portal systemic shunt-induced minimal HE<sup><a href="#ref-150">150</a></sup>. Current and potential therapies for HE in CLD and their recommended or studied doses are summarized in <a href="#T2">Table 2</a>.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Overview of the discussed (potential) treatment options for HE in CLD and their recommended or studied doses.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15633e978 class=n-a></a><thead><a name=d15633e980 class=n-a></a><tr><a name=d15633e982 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15633e984 class=n-a></a>Treatment</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15633e987 class=n-a></a>Drug</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15633e990 class=n-a></a>Recommended/studied dose</th></tr></thead><tbody><a name=d15633e995 class=n-a></a><tr><a name=d15633e997 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e999 class=n-a></a>Non-absorbable disaccharides</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1002 class=n-a></a>Lactulose</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1005 class=n-a></a>Initial dose 25 mL. Dose titration<br class=br>to maintain 23 loose bowel<br class=br>movements/day.</td></tr><tr><a name=d15633e1013 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1015 class=n-a></a>Antibiotics</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1018 class=n-a></a>Rifaximin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1021 class=n-a></a>550 mg BD orally</td></tr><tr><a name=d15633e1025 class=n-a></a><td align=left colspan=1 rowspan=5><a name=d15633e1027 class=n-a></a>Ammonia/nitrogen scavengers</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1030 class=n-a></a>LOLA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1033 class=n-a></a>2540 g/day (i.v.)</td></tr><tr><a name=d15633e1037 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1039 class=n-a></a>OP</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1042 class=n-a></a>Up to 20 g/day (i.v.)</td></tr><tr><a name=d15633e1046 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1048 class=n-a></a>Sodium benzoate</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1051 class=n-a></a>10 g/day (oral)</td></tr><tr><a name=d15633e1056 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1058 class=n-a></a>Sodium phenylbutyrate</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1061 class=n-a></a>200 mg/kg/day (oral or via<br class=br>nasogastric tube)</td></tr><tr><a name=d15633e1067 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1069 class=n-a></a>Glycerol phenylbutyrate</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1072 class=n-a></a>6 mL twice daily for 16 weeks (oral)</td></tr><tr><a name=d15633e1076 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1078 class=n-a></a>Albumin dialysis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1081 class=n-a></a>MARS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1084 class=n-a></a>various</td></tr><tr><a name=d15633e1088 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1090 class=n-a></a>Probiotics</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1093 class=n-a></a>various</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1096 class=n-a></a>various</td></tr><tr><a name=d15633e1100 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1102 class=n-a></a>FMT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1105 class=n-a></a>n.a.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1108 class=n-a></a>various</td></tr><tr><a name=d15633e1112 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1114 class=n-a></a>BCAAs</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1117 class=n-a></a>n.a.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1120 class=n-a></a>various (13.260 g/day)</td></tr><tr><a name=d15633e1125 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1127 class=n-a></a>Zinc</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1130 class=n-a></a>n.a.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1133 class=n-a></a>various (50600 g/day)</td></tr><tr><a name=d15633e1137 class=n-a></a><td align=left colspan=1 rowspan=3><a name=d15633e1139 class=n-a></a>Selection of experimental<br class=br>therapies targeting<br class=br>neuroinflammation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1146 class=n-a></a>Indomethacin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1149 class=n-a></a>0.5 mg/kg i.v.</td></tr><tr><a name=d15633e1153 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1155 class=n-a></a>Sildenafil</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1158 class=n-a></a>unknown</td></tr><tr><a name=d15633e1162 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1164 class=n-a></a>SB239063<br class=br>(MAP-kinase-p38<br class=br>inhibitor)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15633e1171 class=n-a></a>unknown</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d15633e1179 class=n-a></a><p id=d15633e1181> BCAA, branched-chain amino acid; BD, twice daily; FMT, fecal microbiota transplantation; HE, hepatic encephalopathy; i.v., intravenously; LOLA, L-ornithine L-aspartate; OP, ornithine phenylacetate.</p></div></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15633e1191>Conclusion</h2><p class="" id=d15633e1194>HE is a devastating complication of end-stage liver disease with an ever-persisting impact on morbidity, hospitalization, and mortality. Currently available therapies in clinical practice are limited, and the development of novel approaches has been hampered by the complexity and heterogeneity of the syndrome. Traditionally, elevated levels of the neurotoxin ammonia have been considered to be the key driver of portal-systemic HE. In the last few decades, the involvement of extrahepatic organs in ammonia metabolism and the role of systemic and neurological inflammation in the pathogenesis of HE have been more and more established and gained their role in clinical management (<a href="#f1">Figure 1</a>). The development of novel therapies is currently mainly focusing on scavenging ammonia and modulating the gut microbiome, which are attractive potential treatment approaches. The synergistic relationship between ammonia and inflammation in modulating the severity of HE needs to be further explored, as it might provide us with effective novel therapeutic targets, especially in the setting of an acute bout of HE in CLD.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/24468/9a7e1196-237f-4637-b051-270ddb09da1a_figure1.gif"><img alt="9a7e1196-237f-4637-b051-270ddb09da1a_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/24468/9a7e1196-237f-4637-b051-270ddb09da1a_figure1.gif"></a><div class=caption><h3>Figure 1. Multi-organ mechanisms of ammonia production and metabolization and its interaction with inflammation in the pathogenesis of hepatic encephalopathy.</h3><p id=d15633e1210>BCAAs, branched-chain amino acids; DAMPs, damage-associated molecular patterns; PAMPs, pathogen-associated molecular patterns.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15633e1220>Abbreviations</h2><p class="" id=d15633e1223>BBB, bloodbrain barrier; BCAA, branch-chained amino acid; CBF, cerebral blood flow; cGMP, cyclic guanine monophosphate; CLD, chronic liver disease; ETC, electron transport chain; FMT, fecal microbiota transplantation; GS, glutamine synthetase; HE, hepatic encephalopathy; LOLA, L-ornithine L-aspartate; LPS, lipopolysaccharide; mHE, minimal HE; MSO, L-methionine-S,R-sulfoximine; NMDA, N-methyl-D-aspartate; NO, nitric oxide; OP, ornithine phenylacetate; PAMP, pathogen-associated molecular pattern; PTP, permeability transition pore; ROS, reactive oxygen species; TCA, tricarboxylic acid.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d15633e1230 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d16498>References</h2><div class="section ref-list"><a name=d15633e1230 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d15633e1237 class=n-a></a>Vilstrup H, Amodio P, Bajaj J, <i> et al.</i>: Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. <i>Hepatology.</i> 2014; <b>60</b>(2): 71535. <a target=xrefwindow id=d15633e1248 href="http://www.ncbi.nlm.nih.gov/pubmed/25042402">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1251 href="https://doi.org/10.1002/hep.27210">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d15633e1260 class=n-a></a>Stepanova M, Mishra A, Venkatesan C, <i> et al.</i>: In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. <i>Clin Gastroenterol Hepatol.</i> 2012; <b>10</b>(9): 103441.e1. <a target=xrefwindow id=d15633e1271 href="http://www.ncbi.nlm.nih.gov/pubmed/22642955">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1274 href="https://doi.org/10.1016/j.cgh.2012.05.016">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d15633e1283 class=n-a></a>Poordad FF: Review article: the burden of hepatic encephalopathy. <i>Aliment Pharmacol Ther.</i> 2007; <b>25</b>(Suppl 1): 39. <a target=xrefwindow id=d15633e1291 href="http://www.ncbi.nlm.nih.gov/pubmed/17295846">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1294 href="https://doi.org/10.1111/j.1746-6342.2006.03215.x">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d15633e1303 class=n-a></a>D'Amico G, Morabito A, Pagliaro L, <i> et al.</i>: Survival and prognostic indicators in compensated and decompensated cirrhosis. <i>Dig Dis Sci.</i> 1986; <b>31</b>(5): 46875. <a target=xrefwindow id=d15633e1314 href="http://www.ncbi.nlm.nih.gov/pubmed/3009109">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1317 href="https://doi.org/10.1007/bf01320309">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d15633e1326 class=n-a></a>Bajaj JS, Reddy KR, Tandon P, <i> et al.</i>: The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. <i>Hepatology.</i> 2016; <b>64</b>(1): 2008. <a target=xrefwindow id=d15633e1337 href="http://www.ncbi.nlm.nih.gov/pubmed/26690389">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1340 href="https://doi.org/10.1002/hep.28414">Publisher Full Text </a> | <a target=xrefwindow id=d15633e1344 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4700508">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d15633e1354 class=n-a></a>Cordoba J, Ventura-Cots M, Simn-Talero M, <i> et al.</i>: Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). <i>J Hepatol.</i> 2014; <b>60</b>(2): 27581. <a target=xrefwindow id=d15633e1365 href="http://www.ncbi.nlm.nih.gov/pubmed/24128414">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1368 href="https://doi.org/10.1016/j.jhep.2013.10.004">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d15633e1377 class=n-a></a>Romero-Gmez M, Montagnese S, Jalan R: Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. <i>J Hepatol.</i> 2015; <b>62</b>(2): 43747. <a target=xrefwindow id=d15633e1385 href="http://www.ncbi.nlm.nih.gov/pubmed/25218789">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1388 href="https://doi.org/10.1016/j.jhep.2014.09.005">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d15633e1397 class=n-a></a>Blei AT, Crdoba J, Practice Parameters Committee of the American College of Gastroenterology: Hepatic Encephalopathy. <i>Am J Gastroenterol.</i> 2001; <b>96</b>(7): 196876. <a target=xrefwindow id=d15633e1405 href="http://www.ncbi.nlm.nih.gov/pubmed/11467622">PubMed Abstract </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d15633e1414 class=n-a></a>Albrecht J, Norenberg MD: Glutamine: a Trojan horse in ammonia neurotoxicity. <i>Hepatology.</i> 2006; <b>44</b>(4): 78894. <a target=xrefwindow id=d15633e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/17006913">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1425 href="https://doi.org/10.1002/hep.21357">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d15633e1434 class=n-a></a>Welbourne T, Weber M, Bank N: The effect of glutamine administration on urinary ammonium excretion in normal subjects and patients with renal disease. <i>J Clin Invest.</i> 1972; <b>51</b>(7): 185260. <a target=xrefwindow id=d15633e1442 href="http://www.ncbi.nlm.nih.gov/pubmed/4555786">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1445 href="https://doi.org/10.1172/JCI106987">Publisher Full Text </a> | <a target=xrefwindow id=d15633e1448 href="http://www.ncbi.nlm.nih.gov/pmc/articles/292333">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d15633e1457 class=n-a></a>Matthews SA: Ammonia, a causative factor in meat poisoning in Eck fistula dogs. <i>Am J Physiol.</i> 1922; <b>59</b>: 459460. </span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d15633e1473 class=n-a></a>Sherlock S, Summerskill WH, White L, Phear E: Portal-systemic encephalopathy; neurological complications of liver disease. <i>Lancet.</i> 1954; <b>264</b>(6836): 4537. <a target=xrefwindow id=d15633e1481 href="http://www.ncbi.nlm.nih.gov/pubmed/13193045">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1484 href="https://doi.org/10.1016/S0140-6736(54)91874-7">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d15633e1493 class=n-a></a>Bosoi CR, Rose CF: Identifying the direct effects of ammonia on the brain. <i>Metab Brain Dis.</i> 2009; <b>24</b>(1): 95102. <a target=xrefwindow id=d15633e1501 href="http://www.ncbi.nlm.nih.gov/pubmed/19104924">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1504 href="https://doi.org/10.1007/s11011-008-9112-7">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d15633e1513 class=n-a></a>Martinez-Hernandez A, Bell K, Norenberg M: Glutamine synthetase: glial localization in brain. <i>Science.</i> 1977; <b>195</b>(4284): 13568. <a target=xrefwindow id=d15633e1521 href="http://www.ncbi.nlm.nih.gov/pubmed/14400">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1524 href="https://doi.org/10.1126/science.14400">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d15633e1533 class=n-a></a>Norenberg MD, Martinez-Hernandez A: Fine structural localization of glutamine synthetase in astrocytes of rat brain. <i>Brain Res.</i> 1979; <b>161</b>(2): 30310. <a target=xrefwindow id=d15633e1541 href="http://www.ncbi.nlm.nih.gov/pubmed/31966">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1544 href="https://doi.org/10.1016/0006-8993(79)90071-4">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d15633e1553 class=n-a></a>Cooper AJ, Mora SN, Cruz NF, <i> et al.</i>: Cerebral ammonia metabolism in hyperammonemic rats. <i>J Neurochem.</i> 1985; <b>44</b>(6): 171623. <a target=xrefwindow id=d15633e1564 href="http://www.ncbi.nlm.nih.gov/pubmed/2859353">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1567 href="https://doi.org/10.1111/j.1471-4159.1985.tb07159.x">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d15633e1576 class=n-a></a>Lavoie J, Gigure JF, Layrargues GP, <i> et al.</i>: Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. <i>J Neurochem.</i> 1987; <b>49</b>(3): 6927. <a target=xrefwindow id=d15633e1587 href="http://www.ncbi.nlm.nih.gov/pubmed/2886551">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1590 href="https://doi.org/10.1111/j.1471-4159.1987.tb00949.x">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d15633e1600 class=n-a></a>Cooper AJ, Plum F: Biochemistry and physiology of brain ammonia. <i>Physiol Rev.</i> 1987; <b>67</b>(2): 440519. <a target=xrefwindow id=d15633e1608 href="http://www.ncbi.nlm.nih.gov/pubmed/2882529">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1611 href="https://doi.org/10.1152/physrev.1987.67.2.440">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d15633e1620 class=n-a></a>Matheson DF, van den Berg CJ: Ammonia and brain glutamine: inhibition of glutamine degradation by ammonia. <i>Biochem Soc Trans.</i> 1975; <b>3</b>(4): 5258. <a target=xrefwindow id=d15633e1628 href="http://www.ncbi.nlm.nih.gov/pubmed/1183715">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1631 href="https://doi.org/10.1042/bst0030525">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d15633e1640 class=n-a></a>Norenberg MD: The astrocyte in liver disease. <i>Adv Cell Neurobiol.</i> 1981; <b>2</b>: 303352. <a target=xrefwindow id=d15633e1648 href="http://www.ncbi.nlm.nih.gov/pubmed/4109954">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1651 href="https://doi.org/10.1016/B978-0-12-008302-2.50013-4">Publisher Full Text </a> | <a target=xrefwindow id=d15633e1654 href="http://www.ncbi.nlm.nih.gov/pmc/articles/xxx">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d15633e1663 class=n-a></a>Blanger M, Desjardins P, Chatauret N, <i> et al.</i>: Loss of expression of glial fibrillary acidic protein in acute hyperammonemia. <i>Neurochem Int.</i> 2002; <b>41</b>(23): 15560. <a target=xrefwindow id=d15633e1674 href="http://www.ncbi.nlm.nih.gov/pubmed/12020615">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1677 href="https://doi.org/10.1016/s0197-0186(02)00037-2">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d15633e1686 class=n-a></a>Neary JT, Whittemore SR, Zhu Q, <i> et al.</i>: Destabilization of glial fibrillary acidic protein mRNA in astrocytes by ammonia and protection by extracellular ATP. <i>J Neurochem.</i> 1994; <b>63</b>(6): 20217. <a target=xrefwindow id=d15633e1697 href="http://www.ncbi.nlm.nih.gov/pubmed/7964719">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1700 href="https://doi.org/10.1046/j.1471-4159.1994.63062021.x">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d15633e1709 class=n-a></a>Desjardins P, Bandeira P, Raghavendra Rao VL, <i> et al.</i>: Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein mRNA in brain following portacaval anastomosis. <i>Brain Res.</i> 1997; <b>758</b>(12): 2558. <a target=xrefwindow id=d15633e1720 href="http://www.ncbi.nlm.nih.gov/pubmed/9203558">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1723 href="https://doi.org/10.1016/s0006-8993(97)00339-9">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d15633e1733 class=n-a></a>Gigure J-F, Hamel E, Butterworth RF: Increased densities of binding sites for the peripheral-type benzodiazepine receptor ligand [<sup>3</sup>H]PK 11195 in rat brain following portacaval anastomosis. <i>Brain Res.</i> 1992; <b>585</b>(12): 2958. <a target=xrefwindow id=d15633e1744 href="http://www.ncbi.nlm.nih.gov/pubmed/1324770">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1747 href="https://doi.org/10.1016/0006-8993(92)91222-z">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d15633e1756 class=n-a></a>Lavoie J, Layrargues GP, Butterworth RF: Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy. <i>Hepatology.</i> 1990; <b>11</b>(5): 8748. <a target=xrefwindow id=d15633e1764 href="http://www.ncbi.nlm.nih.gov/pubmed/2161396">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1767 href="https://doi.org/10.1002/hep.1840110524">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d15633e1776 class=n-a></a>Thort Y, Bossu JL: Effects of ammonium salts on synaptic transmission to hippocampal CA1 and CA3 pyramidal cells <i>in vivo</i>. <i>Neuroscience.</i> 1985; <b>14</b>(3): 80721. <a target=xrefwindow id=d15633e1787 href="http://www.ncbi.nlm.nih.gov/pubmed/2859553">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1790 href="https://doi.org/10.1016/0306-4522(85)90145-9">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d15633e1799 class=n-a></a>Rao VL, Agrawal AK, Murthy CR: Ammonia-induced alterations in glutamate and muscimol binding to cerebellar synaptic membranes. <i>Neurosci Lett.</i> 1991; <b>130</b>(2): 2514. <a target=xrefwindow id=d15633e1807 href="http://www.ncbi.nlm.nih.gov/pubmed/1686641">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1810 href="https://doi.org/10.1016/0304-3940(91)90408-l">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d15633e1819 class=n-a></a>Hermenegildo C, Montoliu C, Llansola M, <i> et al.</i>: Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat <i>in vivo</i>. <i>Eur J Neurosci.</i> 1998; <b>10</b>(10): 32019. <a target=xrefwindow id=d15633e1833 href="http://www.ncbi.nlm.nih.gov/pubmed/9786213">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1837 href="https://doi.org/10.1046/j.1460-9568.1998.00329.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d15633e1846 class=n-a></a>Posner JB, Plum F: The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. <i>J Clin Invest.</i> 1960; <b>39</b>: 124658. <a target=xrefwindow id=d15633e1854 href="http://www.ncbi.nlm.nih.gov/pubmed/14434376">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1857 href="https://doi.org/10.1172/JCI104140">Publisher Full Text </a> | <a target=xrefwindow id=d15633e1860 href="http://www.ncbi.nlm.nih.gov/pmc/articles/441871">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d15633e1870 class=n-a></a>James IM, Garassini M: Effect of lactulose on cerebral metabolism in patients with chronic portosystemic encephalopathy. <i>Gut.</i> 1971; <b>12</b>(9): 7024. <a target=xrefwindow id=d15633e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/5098325">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1881 href="https://doi.org/10.1136/gut.12.9.702">Publisher Full Text </a> | <a target=xrefwindow id=d15633e1884 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1411795">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d15633e1893 class=n-a></a>Iversen P, Srensen M, Bak LK, <i> et al.</i>: Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. <i>Gastroenterology.</i> 2009; <b>136</b>(3): 86371. <a target=xrefwindow id=d15633e1904 href="http://www.ncbi.nlm.nih.gov/pubmed/19041869">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1907 href="https://doi.org/10.1053/j.gastro.2008.10.057">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d15633e1916 class=n-a></a>Dam G, Keiding S, Munk OL, <i> et al.</i>: Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. <i>Hepatology.</i> 2013; <b>57</b>(1): 25865. <a target=xrefwindow id=d15633e1927 href="http://www.ncbi.nlm.nih.gov/pubmed/22886493">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1930 href="https://doi.org/10.1002/hep.25995">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d15633e1939 class=n-a></a>McCandless DW, Schenker S: Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system. <i>Exp Brain Res.</i> 1981; <b>44</b>(3): 32530. <a target=xrefwindow id=d15633e1947 href="http://www.ncbi.nlm.nih.gov/pubmed/7308346">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1950 href="https://doi.org/10.1007/bf00236570">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d15633e1959 class=n-a></a>Hawkins RA, Miller AL, Nielsen RC, <i> et al.</i>: The acute action of ammonia on rat brain metabolism <i>in vivo</i>. <i>Biochem J.</i> 1973; <b>134</b>(4): 10018. <a target=xrefwindow id=d15633e1973 href="http://www.ncbi.nlm.nih.gov/pubmed/4762748">PubMed Abstract </a> | <a target=xrefwindow id=d15633e1977 href="https://doi.org/10.1042/bj1341001">Publisher Full Text </a> | <a target=xrefwindow id=d15633e1980 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1177908">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d15633e1989 class=n-a></a>Lockwood AH, Murphy BW, Donnelly KZ, <i> et al.</i>: Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. <i>Hepatology.</i> 1993; <b>18</b>(5): 10618. <a target=xrefwindow id=d15633e2000 href="http://www.ncbi.nlm.nih.gov/pubmed/8225210">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2003 href="https://doi.org/10.1002/hep.1840180508">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d15633e2013 class=n-a></a>Felipo V, Butterworth RF: Neurobiology of ammonia. <i>Prog Neurobiol.</i> 2002; <b>67</b>(4): 25979. <a target=xrefwindow id=d15633e2021 href="http://www.ncbi.nlm.nih.gov/pubmed/12207972">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2024 href="https://doi.org/10.1016/s0301-0082(02)00019-9">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d15633e2033 class=n-a></a>Bessman SP, Bessman AN: The cerebral and peripheral uptake of ammonia in liver disease with an hypothesis for the mechanism of hepatic coma. <i>J Clin Invest.</i> 1955; <b>34</b>(4): 6228. <a target=xrefwindow id=d15633e2041 href="http://www.ncbi.nlm.nih.gov/pubmed/14367516">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2044 href="https://doi.org/10.1172/JCI103111">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2047 href="http://www.ncbi.nlm.nih.gov/pmc/articles/438668">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d15633e2056 class=n-a></a>Muntz JA, Hurwitz J: Effect of potassium and ammonium ions upon glycolysis catalyzed by an extract of rat brain. <i>Arch Biochem Biophys.</i> 1951; <b>32</b>(1): 12436. <a target=xrefwindow id=d15633e2064 href="http://www.ncbi.nlm.nih.gov/pubmed/14847673">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2067 href="https://doi.org/10.1016/0003-9861(51)90246-9">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d15633e2076 class=n-a></a>Abrahams SL, Younathan ES: Modulation of the kinetic properties of phosphofructokinase by ammonium ions. <i>J Biol Chem.</i> 1971; <b>246</b>(8): 24647. <a target=xrefwindow id=d15633e2084 href="http://www.ncbi.nlm.nih.gov/pubmed/4251852">PubMed Abstract </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d15633e2093 class=n-a></a>Ratnakumari L, Qureshi IA, Butterworth RF: Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. <i>Biochem Biophys Res Commun.</i> 1992; <b>184</b>(2): 74651. <a target=xrefwindow id=d15633e2101 href="http://www.ncbi.nlm.nih.gov/pubmed/1575747">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2104 href="https://doi.org/10.1016/0006-291x(92)90653-3">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d15633e2113 class=n-a></a>Shorey J, McCandless DW, Schenker S: Cerebral alpha-ketoglutarate in ammonia intoxication. <i>Gastroenterology.</i> 1967; <b>53</b>(5): 70611. <a target=xrefwindow id=d15633e2121 href="http://www.ncbi.nlm.nih.gov/pubmed/6061358">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2124 href="https://doi.org/10.1016/S0016-5085(19)34154-X">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d15633e2134 class=n-a></a>Lai JC, Cooper AJ: Neurotoxicity of ammonia and fatty acids: differential inhibition of mitochondrial dehydrogenases by ammonia and fatty acyl coenzyme A derivatives. <i>Neurochem Res.</i> 1991; <b>16</b>(7): 795803. <a target=xrefwindow id=d15633e2142 href="http://www.ncbi.nlm.nih.gov/pubmed/1944769">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2145 href="https://doi.org/10.1007/bf00965689">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d15633e2154 class=n-a></a>Walshe JM, de Carli L, Davidson CS: Some factors influencing cerebral ammonia production in relation to hepatic coma. <i>Clin Sci.</i> 1958; <b>17</b>(1): 2736. <a target=xrefwindow id=d15633e2162 href="http://www.ncbi.nlm.nih.gov/pubmed/13511717">PubMed Abstract </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d15633e2171 class=n-a></a>McKhann GM, Tower DB: Ammonia toxicity and cerebral oxidative metabolism. <i>Am J Physiol.</i> 1961; <b>200</b>: 4204. <a target=xrefwindow id=d15633e2179 href="http://www.ncbi.nlm.nih.gov/pubmed/13774048">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2182 href="https://doi.org/10.1152/ajplegacy.1961.200.3.420">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d15633e2191 class=n-a></a>Kosenko E, Felipo V, Montoliu C, <i> et al.</i>: Effects of acute hyperammonemia <i>in vivo</i> on oxidative metabolism in nonsynaptic rat brain mitochondria. <i>Metab Brain Dis.</i> 1997; <b>12</b>(1): 6982. <a target=xrefwindow id=d15633e2205 href="http://www.ncbi.nlm.nih.gov/pubmed/9101539">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2209 href="https://doi.org/10.1007/bf02676355">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d15633e2218 class=n-a></a>Kala G, Hertz L: Ammonia effects on pyruvate/lactate production in astrocytes--interaction with glutamate. <i>Neurochem Int.</i> 2005; <b>47</b>(412): 412. <a target=xrefwindow id=d15633e2226 href="http://www.ncbi.nlm.nih.gov/pubmed/15890434">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2229 href="https://doi.org/10.1016/j.neuint.2005.04.001">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d15633e2238 class=n-a></a>Rama Rao KV, Norenberg MD: Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. <i>Neurochem Int.</i> 2012; <b>60</b>(7): 697706. <a target=xrefwindow id=d15633e2246 href="http://www.ncbi.nlm.nih.gov/pubmed/21989389">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2249 href="https://doi.org/10.1016/j.neuint.2011.09.007">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2252 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4714837">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d15633e2262 class=n-a></a>Hindfelt B, Plum F, Duffy TE: Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. <i>J Clin Invest.</i> 1977; <b>59</b>(3): 38696. <a target=xrefwindow id=d15633e2270 href="http://www.ncbi.nlm.nih.gov/pubmed/838855">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2273 href="https://doi.org/10.1172/JCI108651">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2276 href="http://www.ncbi.nlm.nih.gov/pmc/articles/333373">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d15633e2285 class=n-a></a>Astore D, Boicelli CA: Hyperammonemia and chronic hepatic encephalopathy: an <i>in vivo</i> PMRS study of the rat brain. <i>MAGMA.</i> 2000; <b>10</b>(3): 1606. <a target=xrefwindow id=d15633e2296 href="http://www.ncbi.nlm.nih.gov/pubmed/10873206">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2299 href="https://doi.org/10.1007/bf02590641">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d15633e2308 class=n-a></a>Rao KV, Mawal YR, Qureshi IA: Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-<span style="font-variant: small-caps">L</span>-carnitine in restoring the ammonia-induced cerebral energy depletion. <i>Neurosci Lett.</i> 1997; <b>224</b>(2): 836. <a target=xrefwindow id=d15633e2319 href="http://www.ncbi.nlm.nih.gov/pubmed/9086462">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2322 href="https://doi.org/10.1016/s0304-3940(97)13476-0">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d15633e2331 class=n-a></a>Bernardi P, Colonna R, Costantini P, <i> et al.</i>: The mitochondrial permeability transition. <i>Biofactors.</i> 1998; <b>8</b>(34): 27381. <a target=xrefwindow id=d15633e2342 href="https://doi.org/10.1002/biof.5520080315">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d15633e2351 class=n-a></a>Norenberg M, Rao K: The mitochondrial permeability transition in neurologic disease. <i>Neurochem Int.</i> 2007; <b>50</b>(78): 98397. <a target=xrefwindow id=d15633e2359 href="http://www.ncbi.nlm.nih.gov/pubmed/17397969">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2362 href="https://doi.org/10.1016/j.neuint.2007.02.008">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2365 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4714712">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d15633e2374 class=n-a></a>Kristal BS, Dubinsky JM: Mitochondrial Permeability Transition in the Central Nervous System: Induction by Calcium Cycling-Dependent and -Independent Pathways. <i>J Neurochem.</i> 1997; <b>69</b>(2): 52438. <a target=xrefwindow id=d15633e2382 href="https://doi.org/10.1046/j.1471-4159.1997.69020524.x.">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d15633e2392 class=n-a></a>Norenberg MD, Rama Rao KV, Jayakumar AR: The mitochondrial permeability transition in ammonia neurotoxicity. In: Jones E, Meijer AJ, Chamuleau AF, editors. <i>Encephalopathy and Nitrogen Metabolism in Liver Failure</i>. Dordrecht: Kluwer; 2003; 267286. <a target=xrefwindow id=d15633e2397 href="https://link.springer.com/chapter/10.1007/978-94-010-0159-5_28">Reference Source</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d15633e2406 class=n-a></a>Rose C: Effect of ammonia on astrocytic glutamate uptake/release mechanisms. <i>J Neurochem.</i> 2006; <b>97</b>(Suppl 1): 115. <a target=xrefwindow id=d15633e2414 href="http://www.ncbi.nlm.nih.gov/pubmed/16635245">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2417 href="https://doi.org/10.1111/j.1471-4159.2006.03796.x">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d15633e2426 class=n-a></a>Jayakumar AR, Rama Rao KV, Tong XY, <i> et al.</i>: Calcium in the mechanism of ammonia-induced astrocyte swelling. <i>J Neurochem.</i> 2009; <b>109</b>(Suppl 1): 2527. <a target=xrefwindow id=d15633e2437 href="http://www.ncbi.nlm.nih.gov/pubmed/19393035">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2440 href="https://doi.org/10.1111/j.1471-4159.2009.05842.x">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2444 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4737088">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d15633e2453 class=n-a></a>Bai G, Rama Rao KV, Murthy CR, <i> et al.</i>: Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. <i>J Neurosci Res.</i> 2001; <b>66</b>(5): 98191. <a target=xrefwindow id=d15633e2464 href="http://www.ncbi.nlm.nih.gov/pubmed/11746427">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2467 href="https://doi.org/10.1002/jnr.10056">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d15633e2476 class=n-a></a>Grg B, Karababa A, Shafigullina A, <i> et al.</i>: Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. <i>Glia.</i> 2015; <b>63</b>(1): 3750. <a target=xrefwindow id=d15633e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/25092802">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2490 href="https://doi.org/10.1002/glia.22731">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736146658"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e2499 class=n-a></a>Grg B, Karababa A, Schtz E, <i> et al.</i>: O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced oxidative stress and senescence in hepatic encephalopathy. <i>J Hepatol.</i> 2019; <b>71</b>(5): 93041. <a target=xrefwindow id=d15633e2510 href="http://www.ncbi.nlm.nih.gov/pubmed/31279900">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2513 href="https://doi.org/10.1016/j.jhep.2019.06.020">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736146658">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d15633e2527 class=n-a></a>Lockwood AH: Blood ammonia levels and hepatic encephalopathy. <i>Metab Brain Dis.</i> 2004; <b>19</b>(34): 3459. <a target=xrefwindow id=d15633e2535 href="http://www.ncbi.nlm.nih.gov/pubmed/15554426">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2538 href="https://doi.org/10.1023/b:mebr.0000043980.74574.eb">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d15633e2547 class=n-a></a>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. <i>Crit Care Med.</i> 1992; <b>20</b>(6): 86474. <a target=xrefwindow id=d15633e2555 href="http://www.ncbi.nlm.nih.gov/pubmed/1597042">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2558 href="https://doi.org/10.1097/00003246-199206000-00025">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d15633e2567 class=n-a></a>Papadopoulos MC, Davies DC, Moss RF, <i> et al.</i>: Pathophysiology of septic encephalopathy: a review. <i>Crit Care Med.</i> 2000; <b>28</b>(8): 301924. <a target=xrefwindow id=d15633e2578 href="http://www.ncbi.nlm.nih.gov/pubmed/10966289">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2581 href="https://doi.org/10.1097/00003246-200008000-00057">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d15633e2590 class=n-a></a>Shawcross DL, Sharifi Y, Canavan JB, <i> et al.</i>: Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. <i>J Hepatol.</i> 2011; <b>54</b>(4): 6409. <a target=xrefwindow id=d15633e2601 href="http://www.ncbi.nlm.nih.gov/pubmed/21163546">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2604 href="https://doi.org/10.1016/j.jhep.2010.07.045">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735332932"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e2613 class=n-a></a>Irvine KM, Ratnasekera I, Powell EE, <i> et al.</i>: Causes and Consequences of Innate Immune Dysfunction in Cirrhosis. <i>Front Immunol.</i> 2019; <b>10</b>: 293. <a target=xrefwindow id=d15633e2624 href="http://www.ncbi.nlm.nih.gov/pubmed/30873165">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2627 href="https://doi.org/10.3389/fimmu.2019.00293">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2631 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6401613">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735332932">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d15633e2644 class=n-a></a>Wein C, Koch H, Popp B, <i> et al.</i>: Minimal hepatic encephalopathy impairs fitness to drive. <i>Hepatology.</i> 2004; <b>39</b>(3): 73945. <a target=xrefwindow id=d15633e2655 href="http://www.ncbi.nlm.nih.gov/pubmed/14999692">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2658 href="https://doi.org/10.1002/hep.20095">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d15633e2668 class=n-a></a>Felipo V, Urios A, Valero P, <i> et al.</i>: Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy. <i>Liver Int.</i> 2013; <b>33</b>(10): 147889. <a target=xrefwindow id=d15633e2679 href="http://www.ncbi.nlm.nih.gov/pubmed/23714168">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2682 href="https://doi.org/10.1111/liv.12206">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733917458"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e2691 class=n-a></a>Azhari H, Swain MG: Role of Peripheral Inflammation in Hepatic Encephalopathy. <i>J Clin Exp Hepatol.</i> 2018; <b>8</b>(3): 281285. <a target=xrefwindow id=d15633e2699 href="http://www.ncbi.nlm.nih.gov/pubmed/30302045">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2702 href="https://doi.org/10.1016/j.jceh.2018.06.008">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2705 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6175767">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733917458">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d15633e2718 class=n-a></a>Bernardi M, Moreau R, Angeli P, <i> et al.</i>: Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. <i>J Hepatol.</i> 2015; <b>63</b>(5): 127284. <a target=xrefwindow id=d15633e2729 href="http://www.ncbi.nlm.nih.gov/pubmed/26192220">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2732 href="https://doi.org/10.1016/j.jhep.2015.07.004">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d15633e2741 class=n-a></a>D'Mello C, Swain MG: Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression. <i>Curr Top Behav Neurosci.</i> 2017; <b>31</b>: 7394. <a target=xrefwindow id=d15633e2749 href="http://www.ncbi.nlm.nih.gov/pubmed/27677781">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2752 href="https://doi.org/10.1007/7854_2016_37">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d15633e2761 class=n-a></a>Capuron L, Miller AH: Immune system to brain signaling: neuropsychopharmacological implications. <i>Pharmacol Ther.</i> 2011; <b>130</b>(2): 22638. <a target=xrefwindow id=d15633e2769 href="http://www.ncbi.nlm.nih.gov/pubmed/21334376">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2772 href="https://doi.org/10.1016/j.pharmthera.2011.01.014">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2775 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3072299">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d15633e2784 class=n-a></a>DiSabato DJ, Quan N, Godbout JP: Neuroinflammation: the devil is in the details. <i>J Neurochem.</i> 2016; <b>139</b>(Suppl 2): 13653. <a target=xrefwindow id=d15633e2792 href="http://www.ncbi.nlm.nih.gov/pubmed/26990767">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2795 href="https://doi.org/10.1111/jnc.13607">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2798 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5025335">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d15633e2808 class=n-a></a>Glass CK, Saijo K, Winner B, <i> et al.</i>: Mechanisms underlying inflammation in neurodegeneration. <i>Cell.</i> 2010; <b>140</b>(6): 91834. <a target=xrefwindow id=d15633e2819 href="http://www.ncbi.nlm.nih.gov/pubmed/20303880">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2822 href="https://doi.org/10.1016/j.cell.2010.02.016">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2873093">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d15633e2835 class=n-a></a>McCoy MK, Tansey MG: TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. <i>J Neuroinflammation.</i> 2008; <b>5</b>: 45. <a target=xrefwindow id=d15633e2843 href="http://www.ncbi.nlm.nih.gov/pubmed/18925972">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2846 href="https://doi.org/10.1186/1742-2094-5-45">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2849 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2577641">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d15633e2858 class=n-a></a>Bajaj JS, Heuman DM, Hylemon PB, <i> et al.</i>: Altered profile of human gut microbiome is associated with cirrhosis and its complications. <i>J Hepatol.</i> 2014; <b>60</b>(5): 9407. <a target=xrefwindow id=d15633e2869 href="http://www.ncbi.nlm.nih.gov/pubmed/24374295">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2872 href="https://doi.org/10.1016/j.jhep.2013.12.019">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2876 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3995845">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d15633e2885 class=n-a></a>Chen Y, Yang F, Lu H, <i> et al.</i>: Characterization of fecal microbial communities in patients with liver cirrhosis. <i>Hepatology.</i> 2011; <b>54</b>(2): 56272. <a target=xrefwindow id=d15633e2896 href="http://www.ncbi.nlm.nih.gov/pubmed/21574172">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2899 href="https://doi.org/10.1002/hep.24423">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d15633e2908 class=n-a></a>Bajaj JS, Ridlon JM, Hylemon PB, <i> et al.</i>: Linkage of gut microbiome with cognition in hepatic encephalopathy. <i>Am J Physiol Gastrointest Liver Physiol.</i> 2012; <b>302</b>(1): G16875. <a target=xrefwindow id=d15633e2919 href="http://www.ncbi.nlm.nih.gov/pubmed/21940902">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2922 href="https://doi.org/10.1152/ajpgi.00190.2011">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2926 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3345956">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d15633e2935 class=n-a></a>Bajaj JS, Betrapally NS, Hylemon PB, <i> et al.</i>: Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. <i>Hepatology.</i> 2015; <b>62</b>(4): 126071. <a target=xrefwindow id=d15633e2946 href="http://www.ncbi.nlm.nih.gov/pubmed/25820757">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2949 href="https://doi.org/10.1002/hep.27819">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2953 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4587995">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735235764"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e2963 class=n-a></a>Bajaj JS, Fagan A, White MB, <i> et al.</i>: Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy. <i>Am J Gastroenterol.</i> 2019; <b>114</b>(7): 108090. <a target=xrefwindow id=d15633e2974 href="http://www.ncbi.nlm.nih.gov/pubmed/30816877">PubMed Abstract </a> | <a target=xrefwindow id=d15633e2977 href="https://doi.org/10.14309/ajg.0000000000000102">Publisher Full Text </a> | <a target=xrefwindow id=d15633e2981 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6610654">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735235764">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d15633e2994 class=n-a></a>Shawcross DL, Davies NA, Williams R, <i> et al.</i>: Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. <i>J Hepatol.</i> 2004; <b>40</b>(2): 24754. <a target=xrefwindow id=d15633e3005 href="http://www.ncbi.nlm.nih.gov/pubmed/14739095">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3008 href="https://doi.org/10.1016/j.jhep.2003.10.016">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d15633e3017 class=n-a></a>Wright G, Davies NA, Shawcross DL, <i> et al.</i>: Endotoxemia produces coma and brain swelling in bile duct ligated rats. <i>Hepatology.</i> 2007; <b>45</b>(6): 151726. <a target=xrefwindow id=d15633e3028 href="http://www.ncbi.nlm.nih.gov/pubmed/17523148">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3031 href="https://doi.org/10.1002/hep.21599">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d15633e3040 class=n-a></a>Pedersen HR, Ring-Larsen H, Olsen NV, <i> et al.</i>: Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital. <i>J Hepatol.</i> 2007; <b>47</b>(2): 24552. <a target=xrefwindow id=d15633e3051 href="http://www.ncbi.nlm.nih.gov/pubmed/17532089">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3054 href="https://doi.org/10.1016/j.jhep.2007.03.026">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d15633e3063 class=n-a></a>Marini JC, Broussard SR: Hyperammonemia increases sensitivity to LPS. <i>Mol Genet Metab.</i> 2006; <b>88</b>(2): 1317. <a target=xrefwindow id=d15633e3071 href="http://www.ncbi.nlm.nih.gov/pubmed/16497529">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3074 href="https://doi.org/10.1016/j.ymgme.2005.12.013">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d15633e3083 class=n-a></a>Rodrigo R, Cauli O, Gomez-Pinedo U, <i> et al.</i>: Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. <i>Gastroenterology.</i> 2010; <b>139</b>(2): 67584. <a target=xrefwindow id=d15633e3094 href="http://www.ncbi.nlm.nih.gov/pubmed/20303348">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3097 href="https://doi.org/10.1053/j.gastro.2010.03.040">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d15633e3107 class=n-a></a>Bezzi P, Domercq M, Vesce S, <i> et al.</i>: Neuron-astrocyte cross-talk during synaptic transmission: Physiological and neuropathological implications. <i>Prog Brain Res.</i> 2001; <b>132</b>: 25565. <a target=xrefwindow id=d15633e3118 href="http://www.ncbi.nlm.nih.gov/pubmed/11544994">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3121 href="https://doi.org/10.1016/S0079-6123(01)32081-2">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d15633e3130 class=n-a></a>Shawcross DL, Wright GA, Stadlbauer V, <i> et al.</i>: Ammonia impairs neutrophil phagocytic function in liver disease. <i>Hepatology.</i> 2008; <b>48</b>(4): 120212. <a target=xrefwindow id=d15633e3141 href="http://www.ncbi.nlm.nih.gov/pubmed/18697192">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3144 href="https://doi.org/10.1002/hep.22474">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d15633e3153 class=n-a></a>Als-Nielsen B, Gluud LL, Gluud C: Non-absorbable disaccharides for hepatic encephalopathy: Systematic review of randomised trials. <i>BMJ.</i> 2004; <b>328</b>(7447): 1046. <a target=xrefwindow id=d15633e3161 href="http://www.ncbi.nlm.nih.gov/pubmed/15054035">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3164 href="https://doi.org/10.1136/bmj.38048.506134.EE">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3167 href="http://www.ncbi.nlm.nih.gov/pmc/articles/403844">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d15633e3176 class=n-a></a>Gluud LL, Vilstrup H, Morgan MY: Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis. <i>Hepatology.</i> 2016; <b>64</b>(3): 90822. <a target=xrefwindow id=d15633e3184 href="http://www.ncbi.nlm.nih.gov/pubmed/27081787">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3187 href="https://doi.org/10.1002/hep.28598">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d15633e3196 class=n-a></a>Courson A, Jones GM, Twilla JD: Treatment of Acute Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes. <i>J Pharm Pract.</i> 2016; <b>29</b>(3): 2127. <a target=xrefwindow id=d15633e3204 href="http://www.ncbi.nlm.nih.gov/pubmed/25586470">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3207 href="https://doi.org/10.1177/0897190014566312">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729268262"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3216 class=n-a></a>Kang SH, Lee YB, Lee JH, <i> et al.</i>: Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. <i>Aliment Pharmacol Ther.</i> 2017; <b>46</b>(9): 845855. <a target=xrefwindow id=d15633e3227 href="http://www.ncbi.nlm.nih.gov/pubmed/28836723">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3230 href="https://doi.org/10.1111/apt.14275">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729268262">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d15633e3244 class=n-a></a>Liu Q, Duan ZP, Ha DK, <i> et al.</i>: Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. <i>Hepatology.</i> 2004; <b>39</b>(5): 14419. <a target=xrefwindow id=d15633e3255 href="http://www.ncbi.nlm.nih.gov/pubmed/15122774">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3258 href="https://doi.org/10.1002/hep.20194">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727176272"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3267 class=n-a></a>Viramontes Hrner D, Avery A, Stow R: The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review. <i>J Clin Gastroenterol.</i> 2017; <b>51</b>(4): 31223. <a target=xrefwindow id=d15633e3275 href="http://www.ncbi.nlm.nih.gov/pubmed/28059938">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3278 href="https://doi.org/10.1097/MCG.0000000000000789">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727176272">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d15633e3291 class=n-a></a>Marlicz W, Wunsch E, Mydlowska M, <i> et al.</i>: The Effect of Short Term Treatment With Probiotic VSL#3 on Various Clinical and Biochemical Parameters in Patients With Liver Cirrhosis. <i>J Physiol Pharmacol.</i> 2016; <b>67</b>(6): 86777. <a target=xrefwindow id=d15633e3302 href="http://www.ncbi.nlm.nih.gov/pubmed/28195067">PubMed Abstract </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d15633e3311 class=n-a></a>Doron S, Snydman DR: Risk and Safety of Probiotics. <i>Clin Infect Dis.</i> 2015; <b>60 Suppl 2</b>: S129S134. <a target=xrefwindow id=d15633e3319 href="http://www.ncbi.nlm.nih.gov/pubmed/25922398">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3322 href="https://doi.org/10.1093/cid/civ085">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4490230">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d15633e3334 class=n-a></a>Hempel S, Newberry S, Ruelaz A, <i> et al.</i>: Safety of Probiotics Used to Reduce Risk and Prevent or Treat Disease. <i>Evid Rep Technol Assess (Full Rep).</i> 2011; (200): 1645. <a target=xrefwindow id=d15633e3342 href="http://www.ncbi.nlm.nih.gov/pubmed/23126627">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3345 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4780970">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d15633e3354 class=n-a></a>Shen TCD, Albenberg L, Bittinger K, <i> et al.</i>: Engineering the Gut Microbiota to Treat Hyperammonemia. <i>J Clin Invest.</i> 2015; <b>125</b>(7): 284150. <a target=xrefwindow id=d15633e3365 href="http://www.ncbi.nlm.nih.gov/pubmed/26098218">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3368 href="https://doi.org/10.1172/JCI79214">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3372 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4563680">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732071420"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3382 class=n-a></a>Wang WW, Zhang Y, Huang XB, <i> et al.</i>: Fecal Microbiota Transplantation Prevents Hepatic Encephalopathy in Rats With Carbon Tetrachloride-Induced Acute Hepatic Dysfunction. <i>World J Gastroenterol.</i> 2017; <b>23</b>(38): 698394. <a target=xrefwindow id=d15633e3393 href="http://www.ncbi.nlm.nih.gov/pubmed/29097871">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3396 href="https://doi.org/10.3748/wjg.v23.i38.6983">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3400 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5658316">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732071420">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727689876"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3413 class=n-a></a>Bajaj JS, Kassam Z, Fagan A, <i> et al.</i>: Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial. <i>Hepatology.</i> 2017; <b>66</b>: 172738. <a target=xrefwindow id=d15633e3424 href="http://www.ncbi.nlm.nih.gov/pubmed/28586116">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3427 href="https://doi.org/10.1002/hep.29306">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3431 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6102730">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727689876">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734897364"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3444 class=n-a></a>Bajaj JS, Fagan A, Gavis EA, <i> et al.</i>: Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis. <i>Gastroenterology.</i> 2019; <b>156</b>(6): 19211923.e3. <a target=xrefwindow id=d15633e3455 href="http://www.ncbi.nlm.nih.gov/pubmed/30664879">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3458 href="https://doi.org/10.1053/j.gastro.2019.01.033">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3462 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6475479">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734897364">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736828592"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3475 class=n-a></a>DeFilipp Z, Bloom PP, Torres Soto M, <i> et al.</i>: Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant. <i>N Engl J Med.</i> 2019; <b>381</b>(21): 204350. <a target=xrefwindow id=d15633e3489 href="http://www.ncbi.nlm.nih.gov/pubmed/31665575">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3493 href="https://doi.org/10.1056/NEJMoa1910437">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736828592">F1000 Recommendation</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734986928"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3506 class=n-a></a>Kircheis G, Lth S: Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy. <i>Drugs.</i> 2019; <b>79</b>(Suppl 1): 239. <a target=xrefwindow id=d15633e3514 href="http://www.ncbi.nlm.nih.gov/pubmed/30706424">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3517 href="https://doi.org/ 10.1007/s40265-018-1023-2">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3520 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6416235">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734986928">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d15633e3533 class=n-a></a>Bai M, Yang Z, Qi X, <i> et al.</i>: l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials. <i>J Gastroenterol Hepatol.</i> 2013; <b>28</b>(5): 78392. <a target=xrefwindow id=d15633e3544 href="http://www.ncbi.nlm.nih.gov/pubmed/23425108">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3547 href="https://doi.org/10.1111/jgh.12142">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733243259"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3557 class=n-a></a>Goh ET, Stokes CS, Sidhu SS, <i> et al.</i>: L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. <i>Cochrane Database Syst Rev.</i> 2018; <b>5</b>: CD012410. <a target=xrefwindow id=d15633e3568 href="http://www.ncbi.nlm.nih.gov/pubmed/29762873">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3571 href="https://doi.org/10.1002/14651858.CD012410.pub2">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3575 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6494563">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733243259">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d15633e3588 class=n-a></a>Bai M, He C, Yin Z, <i> et al.</i>: Randomised clinical trial: L-ornithine-l-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. <i>Aliment Pharmacol Ther.</i> 2014; <b>40</b>(1): 6371. <a target=xrefwindow id=d15633e3599 href="http://www.ncbi.nlm.nih.gov/pubmed/24832463">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3602 href="https://doi.org/10.1111/apt.12795">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732045820"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3611 class=n-a></a>Stravitz RT, Gottfried M, Durkalski V, <i> et al.</i>: Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. <i>Hepatology.</i> 2018; <b>67</b>(3): 10031013. <a target=xrefwindow id=d15633e3622 href="http://www.ncbi.nlm.nih.gov/pubmed/29080224">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3625 href="https://doi.org/10.1002/hep.29621">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3629 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5826861">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732045820">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d15633e3642 class=n-a></a>Ventura-Cots M, Concepcin M, Arranz JA, <i> et al.</i>: Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients. <i>Therap Adv Gastroenterol.</i> 2016; <b>9</b>(6): 823835. <a target=xrefwindow id=d15633e3653 href="http://www.ncbi.nlm.nih.gov/pubmed/27803737">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3656 href="https://doi.org/10.1177/1756283X16658252">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3660 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5076769">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d15633e3669 class=n-a></a>Ventura-Cots M, Arranz JA, Simn-Talero M, <i> et al.</i>: Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study. <i>J Clin Gastroenterol.</i> 2013; <b>47</b>(10): 8817. <a target=xrefwindow id=d15633e3680 href="http://www.ncbi.nlm.nih.gov/pubmed/23751856">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3683 href="https://doi.org/10.1097/MCG.0b013e318299c789">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d15633e3692 class=n-a></a>Batshaw ML, Brusilow S, Waber L, <i> et al.</i>: Treatment of inborn errors of urea synthesis: Activation of alternative pathways of waste nitrogen synthesis and excretion. <i>N Engl J Med.</i> 1982; <b>306</b>(23): 138792. <a target=xrefwindow id=d15633e3703 href="http://www.ncbi.nlm.nih.gov/pubmed/7078580">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3706 href="https://doi.org/10.1056/NEJM198206103062303">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d15633e3716 class=n-a></a>Brusilow S, Tinker J, Batshaw ML: Amino acid acylation: A mechanism of nitrogen excretion in inborn errors of urea synthesis. <i>Science.</i> 1980; <b>207</b>(4431): 65961. <a target=xrefwindow id=d15633e3724 href="http://www.ncbi.nlm.nih.gov/pubmed/6243418">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3727 href="https://doi.org/10.1126/science.6243418">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736004969"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e3736 class=n-a></a>Zacharias HD, Zacharias AP, Gluud LL, <i> et al.</i>: Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. <i>Cochrane Database Syst Rev.</i> 2019; <b>6</b>: CD012334. <a target=xrefwindow id=d15633e3747 href="http://www.ncbi.nlm.nih.gov/pubmed/31204790">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3750 href="https://doi.org/ 10.1002/14651858.CD012334.pub2">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3754 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6572872">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736004969">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d15633e3767 class=n-a></a>Warren KS, Schenker S: Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. <i>J Lab Clin Med.</i> 1964; <b>64</b>: 4429. <a target=xrefwindow id=d15633e3775 href="http://www.ncbi.nlm.nih.gov/pubmed/14215460">PubMed Abstract </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d15633e3784 class=n-a></a>Takahashi H, Koehler RC, Brusilow SW, <i> et al.</i>: Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. <i>Am J Physiol.</i> 1991; <b>261</b>(3 Pt 2): H8259. <a target=xrefwindow id=d15633e3795 href="http://www.ncbi.nlm.nih.gov/pubmed/1679605">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3798 href="https://doi.org/10.1152/ajpheart.1991.261.3.H825">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d15633e3807 class=n-a></a>Blei AT, Olafsson S, Therrien G, <i> et al.</i>: Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. <i>Hepatology.</i> 1994; <b>19</b>(6): 143744. <a target=xrefwindow id=d15633e3818 href="http://www.ncbi.nlm.nih.gov/pubmed/8188174">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3821 href="https://doi.org/10.1002/hep.1840190619">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d15633e3830 class=n-a></a>Willard-Mack CL, Koehler RC, Hirata T, <i> et al.</i>: Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. <i>Neuroscience.</i> 1996; <b>71</b>(2): 58999. <a target=xrefwindow id=d15633e3841 href="http://www.ncbi.nlm.nih.gov/pubmed/9053810">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3844 href="https://doi.org/10.1016/0306-4522(95)00462-9">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d15633e3854 class=n-a></a>Tanigami H, Rebel A, Martin LJ, <i> et al.</i>: Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. <i>Neuroscience.</i> 2005; <b>131</b>(2): 43749. <a target=xrefwindow id=d15633e3865 href="http://www.ncbi.nlm.nih.gov/pubmed/15708485">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3868 href="https://doi.org/10.1016/j.neuroscience.2004.10.045">Publisher Full Text </a> | <a target=xrefwindow id=d15633e3872 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1819407">Free Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d15633e3881 class=n-a></a>Brumback RA, Lapham LW: DNA synthesis in Alzheimer type II astrocytosis. The question of astrocytic proliferation and mitosis in experimentally induced hepatic encephalopathy. <i>Arch Neurol.</i> 1989; <b>46</b>(8): 8458. <a target=xrefwindow id=d15633e3889 href="http://www.ncbi.nlm.nih.gov/pubmed/2757524">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3892 href="https://doi.org/10.1001/archneur.1989.00520440027016">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d15633e3901 class=n-a></a>Gershoff SN, Elvehjem CA: The relative effect of methionine sulfoximine on different animal species. <i>J Nutr.</i> 1951; <b>45</b>(3): 4518. <a target=xrefwindow id=d15633e3909 href="http://www.ncbi.nlm.nih.gov/pubmed/14898331">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3912 href="https://doi.org/10.1093/jn/45.3.451">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d15633e3921 class=n-a></a>Olde Damink SW, Deutz NE, Dejong CH, <i> et al.</i>: Interorgan ammonia metabolism in liver failure. <i>Neurochem Int.</i> 2002; <b>41</b>(23): 17788. <a target=xrefwindow id=d15633e3932 href="http://www.ncbi.nlm.nih.gov/pubmed/12020618">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3935 href="https://doi.org/10.1016/s0197-0186(02)00040-2">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d15633e3944 class=n-a></a>Ganda OP, Ruderman NB: Muscle nitrogen metabolism in chronic hepatic insufficiency. <i>Metab Clin Exp.</i> 1976; <b>25</b>(4): 42735. <a target=xrefwindow id=d15633e3952 href="http://www.ncbi.nlm.nih.gov/pubmed/1263837">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3955 href="https://doi.org/10.1016/0026-0495(76)90075-5">Publisher Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d15633e3964 class=n-a></a>Uribe M, Mrquez MA, Garcia Ramos G, <i> et al.</i>: Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. <i>Dig Dis Sci.</i> 1982; <b>27</b>(12): 110916. <a target=xrefwindow id=d15633e3975 href="http://www.ncbi.nlm.nih.gov/pubmed/6756833">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3978 href="https://doi.org/10.1007/BF01391449">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d15633e3988 class=n-a></a>Holecek M: Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives. <i>Metab Brain Dis.</i> 2014; <b>29</b>(1): 917. <a target=xrefwindow id=d15633e3996 href="http://www.ncbi.nlm.nih.gov/pubmed/23996300">PubMed Abstract </a> | <a target=xrefwindow id=d15633e3999 href="https://doi.org/10.1007/s11011-013-9428-9">Publisher Full Text </a> | <a target=xrefwindow id=d15633e4002 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3930847">Free Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d15633e4011 class=n-a></a>Holecek M, Kandar R, Sispera L, <i> et al.</i>: Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle. <i>Amino Acids.</i> 2011; <b>40</b>(2): 57584. <a target=xrefwindow id=d15633e4022 href="http://www.ncbi.nlm.nih.gov/pubmed/20614225">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4025 href="https://doi.org/10.1007/s00726-010-0679-z">Publisher Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d15633e4034 class=n-a></a>Amodio P, Bemeur C, Butterworth R, <i> et al.</i>: The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. <i>Hepatology.</i> 2013; <b>58</b>(1): 32536. <a target=xrefwindow id=d15633e4045 href="http://www.ncbi.nlm.nih.gov/pubmed/23471642">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4048 href="https://doi.org/10.1002/hep.26370">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d15633e4057 class=n-a></a>Als-Nielsen B, Koretz RL, Kjaergard LL, <i> et al.</i>: Branched-chain amino acids for hepatic encephalopathy. <i>Cochrane Database Syst Rev.</i> 2003; (2): CD001939. <a target=xrefwindow id=d15633e4065 href="http://www.ncbi.nlm.nih.gov/pubmed/12804416">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4068 href="https://doi.org/10.1002/14651858.CD001939">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d15633e4077 class=n-a></a>de Bruijn KM, Blendis LM, Zilm DH, <i> et al.</i>: Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy. <i>Gut.</i> 1983; <b>24</b>(1): 5360. <a target=xrefwindow id=d15633e4088 href="http://www.ncbi.nlm.nih.gov/pubmed/6336714">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4091 href="https://doi.org/10.1136/gut.24.1.53">Publisher Full Text </a> | <a target=xrefwindow id=d15633e4095 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1419916">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d15633e4104 class=n-a></a>Horst D, Grace ND, Conn HO, <i> et al.</i>: Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. <i>Hepatology.</i> 1984; <b>4</b>(2): 27987. <a target=xrefwindow id=d15633e4115 href="http://www.ncbi.nlm.nih.gov/pubmed/6706302">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4118 href="https://doi.org/10.1002/hep.1840040218">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d15633e4128 class=n-a></a>Les I, Doval E, Garca-Martnez R, <i> et al.</i>: Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. <i>Am J Gastroenterol.</i> 2011; <b>106</b>(6): 10818. <a target=xrefwindow id=d15633e4139 href="http://www.ncbi.nlm.nih.gov/pubmed/21326220">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4142 href="https://doi.org/10.1038/ajg.2011.9">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d15633e4151 class=n-a></a>Marchesini G, Bianchi G, Merli M, <i> et al.</i>: Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. <i>Gastroenterology.</i> 2003; <b>124</b>(7): 1792801. <a target=xrefwindow id=d15633e4162 href="http://www.ncbi.nlm.nih.gov/pubmed/12806613">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4165 href="https://doi.org/10.1016/s0016-5085(03)00323-8">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d15633e4174 class=n-a></a>Muto Y, Sato S, Watanabe A, <i> et al.</i>: Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. <i>Clin Gastroenterol Hepatol.</i> 2005; <b>3</b>(7): 70513. <a target=xrefwindow id=d15633e4185 href="http://www.ncbi.nlm.nih.gov/pubmed/16206505">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4188 href="https://doi.org/10.1016/s1542-3565(05)00017-0">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d15633e4197 class=n-a></a>Loomba V, Pawar G, Dhar KL, <i> et al.</i>: Serum zinc levels in hepatic encephalopathy. <i>Indian J Gastroenterol.</i> 1995; <b>14</b>(2): 513. <a target=xrefwindow id=d15633e4208 href="http://www.ncbi.nlm.nih.gov/pubmed/7797277">PubMed Abstract </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d15633e4217 class=n-a></a>Bresci G, Parisi G, Banti S: Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. <i>Eur J Med.</i> 1993; <b>2</b>(7): 4146. <a target=xrefwindow id=d15633e4225 href="http://www.ncbi.nlm.nih.gov/pubmed/8258031">PubMed Abstract </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d15633e4234 class=n-a></a>Reding P, Duchateau J, Bataille C: Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. <i>Lancet.</i> 1984; <b>324</b>(8401): 4935. <a target=xrefwindow id=d15633e4242 href="http://www.ncbi.nlm.nih.gov/pubmed/6147551">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4245 href="https://doi.org/10.1016/s0140-6736(84)92567-4">Publisher Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d15633e4255 class=n-a></a>Riggio O, Ariosto F, Merli M, <i> et al.</i>: Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. <i>Dig Dis Sci.</i> 1991; <b>36</b>(9): 12048. <a target=xrefwindow id=d15633e4266 href="http://www.ncbi.nlm.nih.gov/pubmed/1893805">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4269 href="https://doi.org/10.1007/bf01307509">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d15633e4278 class=n-a></a>Van der Rijt CC, Schalm SW, Schat H, <i> et al.</i>: Overt hepatic encephalopathy precipitated by zinc deficiency. <i>Gastroenterology.</i> 1991; <b>100</b>(4): 11148. <a target=xrefwindow id=d15633e4289 href="http://www.ncbi.nlm.nih.gov/pubmed/2001810">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4292 href="https://doi.org/10.1016/0016-5085(91)90290-2">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d15633e4301 class=n-a></a>Marchesini G, Fabbri A, Bianchi G, <i> et al.</i>: Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. <i>Hepatology.</i> 1996; <b>23</b>(5): 108492. <a target=xrefwindow id=d15633e4312 href="http://www.ncbi.nlm.nih.gov/pubmed/8621138">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4315 href="https://doi.org/10.1053/jhep.1996.v23.pm0008621138">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d15633e4324 class=n-a></a>Takuma Y, Nouso K, Makino Y, <i> et al.</i>: Clinical trial: oral zinc in hepatic encephalopathy. <i>Aliment Pharmacol Ther.</i> 2010; <b>32</b>(9): 108090. <a target=xrefwindow id=d15633e4335 href="http://www.ncbi.nlm.nih.gov/pubmed/20822500">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4338 href="https://doi.org/10.1111/j.1365-2036.2010.04448.x">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736178975"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e4347 class=n-a></a>Shen YC, Chang YH, Fang CJ, <i> et al.</i>: Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. <i>Nutr J.</i> 2019; <b>18</b>(1): 34. <a target=xrefwindow id=d15633e4358 href="http://www.ncbi.nlm.nih.gov/pubmed/31279342">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4361 href="https://doi.org/10.1186/s12937-019-0461-3">Publisher Full Text </a> | <a target=xrefwindow id=d15633e4365 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6612144">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736178975">F1000 Recommendation</a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d15633e4378 class=n-a></a>Cauli O, Rodrigo R, Piedrafita B, <i> et al.</i>: Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. <i>Hepatology.</i> 2007; <b>46</b>(2): 5149. <a target=xrefwindow id=d15633e4389 href="http://www.ncbi.nlm.nih.gov/pubmed/17659565">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4392 href="https://doi.org/10.1002/hep.21734">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d15633e4402 class=n-a></a>Cauli O, Rodrigo R, Piedrafita B, <i> et al.</i>: Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity. <i>J Neurosci Res.</i> 2009; <b>87</b>(6): 136974. <a target=xrefwindow id=d15633e4413 href="http://www.ncbi.nlm.nih.gov/pubmed/19025766">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4416 href="https://doi.org/10.1002/jnr.21947">Publisher Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d15633e4425 class=n-a></a>Ahboucha S, Layrargues GP, Mamer O, <i> et al.</i>: Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. <i>Ann Neurol.</i> 2005; <b>58</b>(1): 16970. <a target=xrefwindow id=d15633e4436 href="http://www.ncbi.nlm.nih.gov/pubmed/15984019">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4439 href="https://doi.org/10.1002/ana.20534">Publisher Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d15633e4448 class=n-a></a>Garcia-Martinez R, Caraceni P, Bernardi M, <i> et al.</i>: Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. <i>Hepatology.</i> 2013; <b>58</b>(5): 183646. <a target=xrefwindow id=d15633e4459 href="http://www.ncbi.nlm.nih.gov/pubmed/23423799">PubMed Abstract </a> | <a target=xrefwindow id=d15633e4462 href="https://doi.org/10.1002/hep.26338">Publisher Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d15633e4471 class=n-a></a>Jalan R, Kapoor D: Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. <i>Clin Sci (Lond).</i> 2004; <b>106</b>(5): 46774. <a target=xrefwindow id=d15633e4479 href="http://www.ncbi.nlm.nih.gov/pubmed/14678008">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4482 href="https://doi.org/10.1042/CS20030357">Publisher Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d15633e4491 class=n-a></a>Simn-Talero M, Garca-Martnez R, Torrens M, <i> et al.</i>: Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. <i>J Hepatol.</i> 2013; <b>59</b>(6): 118492. <a target=xrefwindow id=d15633e4502 href="http://www.ncbi.nlm.nih.gov/pubmed/23872605">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4505 href="https://doi.org/10.1016/j.jhep.2013.07.020">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969216"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e4514 class=n-a></a>Baares R, Nevens F, Larsen FS, <i> et al.</i>: Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. <i>Hepatology.</i> 2013; <b>57</b>(3): 115362. <a target=xrefwindow id=d15633e4525 href="http://www.ncbi.nlm.nih.gov/pubmed/23213075">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4528 href="https://doi.org/10.1002/hep.26185">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969216">F1000 Recommendation</a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d15633e4542 class=n-a></a>Llansola M, Rodrigo R, Monfort P, <i> et al.</i>: NMDA receptors in hyperammonemia and hepatic encephalopathy. <i>Metab Brain Dis.</i> 2007; <b>22</b>(34): 32135. <a target=xrefwindow id=d15633e4553 href="http://www.ncbi.nlm.nih.gov/pubmed/17701332">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4556 href="https://doi.org/10.1007/s11011-007-9067-0">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d15633e4565 class=n-a></a>Erceg S, Monfort P, Hernndez-Viadel M, <i> et al.</i>: Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. <i>Hepatology.</i> 2005; <b>41</b>(2): 299306. <a target=xrefwindow id=d15633e4576 href="http://www.ncbi.nlm.nih.gov/pubmed/15660436">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4579 href="https://doi.org/10.1002/hep.20565">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727455028"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15633e4588 class=n-a></a>Agusti A, Hernndez-Rabaza V, Balzano T, <i> et al.</i>: Sildenafil reduces neuroinflammation in cerebellum, restores GABAergic tone, and improves motor in-coordination in rats with hepatic encephalopathy. <i>CNS Neurosci Ther.</i> 2017; <b>23</b>(5): 38694. <a target=xrefwindow id=d15633e4599 href="http://www.ncbi.nlm.nih.gov/pubmed/28296282">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4602 href="https://doi.org/10.1111/cns.12688">Publisher Full Text </a> | |<a target=xrefwindow id=d15633e4606 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6492705">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727455028">F1000 Recommendation</a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d15633e4619 class=n-a></a>Hernandez-Rabaza V, Agusti A, Cabrera-Pastor A, <i> et al.</i>: Sildenafil reduces neuroinflammation and restores spatial learning in rats with hepatic encephalopathy: underlying mechanisms. <i>J Neuroinflammation.</i> 2015; <b>12</b>: 195. <a target=xrefwindow id=d15633e4630 href="http://www.ncbi.nlm.nih.gov/pubmed/26511444">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4633 href="https://doi.org/10.1186/s12974-015-0420-7">Publisher Full Text </a> | |<a target=xrefwindow id=d15633e4637 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4625867">Free Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d15633e4646 class=n-a></a>Strassburger M, Braun H, Reymann KG: Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. <i>Eur J Pharmacol.</i> 2008; <b>592</b>(13): 5561. <a target=xrefwindow id=d15633e4654 href="http://www.ncbi.nlm.nih.gov/pubmed/18638472">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4657 href="https://doi.org/10.1016/j.ejphar.2008.06.099">Publisher Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d15633e4666 class=n-a></a>Schindler JF, Monahan JB, Smith WG: p38 pathway kinases as anti-inflammatory drug targets. <i>J Dent Res.</i> 2016; <b>86</b>(9): 80011. <a target=xrefwindow id=d15633e4674 href="http://www.ncbi.nlm.nih.gov/pubmed/17720847">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4677 href="https://doi.org/10.1177/154405910708600902">Publisher Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d15633e4687 class=n-a></a>Agusti A, Cauli O, Rodrigo R, <i> et al.</i>: p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. <i>Gut.</i> 2011; <b>60</b>(11): 15729. <a target=xrefwindow id=d15633e4698 href="http://www.ncbi.nlm.nih.gov/pubmed/21636647">PubMed Abstract </a> | |<a target=xrefwindow id=d15633e4701 href="https://doi.org/10.1136/gut.2010.236083">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Apr 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-312/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-312/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Institute for Liver and Digestive Health, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK<br/> <p> <div class=margin-bottom> Annarein J. C. Kerbert <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation </div> <div class=margin-bottom> Rajiv Jalan <br/> <span>Roles: </span> Conceptualization, Supervision, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-312/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Apr 2020, 9:312 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.22183.1">https://doi.org/10.12688/f1000research.22183.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2020 Kerbert AJC and Jalan R. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=24468 data-id=22183 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22183.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-312/v1/pdf?article_uuid=e8c634dd-eea7-466a-8118-5beb9d9eaf4d" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.22183.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Kerbert AJC and Jalan R. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.22183.1" target=_blank>https://doi.org/10.12688/f1000research.22183.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=22183 id=mobile-track-article-signin-22183 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22183?target=/articles/9-312/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=24468 /> <input name=articleId type=hidden value=22183 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Christopher Rose</strong>, Hepato-Neuro Laboratory, Department of Medicine, Universit de Montral, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Marcus-Alexander W&ouml;rns</strong>, Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Christian Labenz</strong>, Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Apr 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-312/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-312/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25428-62903></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=66990-62902></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-312/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Apr 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Christopher Rose</strong>, Hepato-Neuro Laboratory, Department of Medicine, Universit de Montral, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Marcus-Alexander W&ouml;rns</strong>, Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Christian Labenz</strong>, Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-312/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-312/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-312/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-312/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-312/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Kerbert AJC and Jalan R');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-312/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-312",
            templates : {
                twitter : "Recent advances in understanding and managing hepatic encephalopathy.... Kerbert AJC and Jalan R, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-312/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/22183/24468")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "24468");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "62902": 4,
                           "62903": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "e9fbddc9-8004-4365-94e0-ed5821771b9c";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-312.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-312.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-312.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-312.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-312.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>